↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

1,322 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   (11c)pe2i   -   -   -   -   1件:
6 
 2   (2-chloro-5-[11c]methoxy-n-(((3s,5s,7s)-3,5,7-trifluoroadamantan-1-yl)methyl) benzamide)   -   -   -   -   1件:
6 
 3   (3beta, 5beta, 25r)-spirostan-3-ol   -   -   -   -   1件:
6 
 4   (3ß, 5ß, 25r)-spirostan-3-ol   -   -   -   -   1件:
6 
 5   (6s)-6-{propyl-[2-[2-thienyl]ethyl]amino}-5,6,7,8-tetrahydro-1-naphtalenol   -   -   -   -   1件:
6 
 6   (r)-troloxamide quinone   -   -   -   -   1件:
6 
 7   (s)- 2- amino- 4,5,6,7- tetrahydro- 6- (propylamino)benzothiazol   -   -   -   -   1件:
6 
 8   (s)-(+)-2-(4-(3-fluorobenzyl)oxybenzyl)aminopropanamide methanesulfonate   -   -   -   -   1件:
6 
 9   0 mg tropicamide   Tropicamide   D00397   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   1件:
6 
 10   0.3 mg tropicamide   Tropicamide   D00397   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   1件:
6 
 11   0.9% sodium chloride   Sodium chloride   D02056   -   -   3件:
6,
14,
51 
 12   0.9% sodium chloride (normal saline)   Sodium chloride   D02056   -   -   1件:
6 
 13   009-0   -   -   -   -   1件:
6 
 14   009-1   -   -   -   -   1件:
6 
 15   009-2   -   -   -   -   1件:
6 
 16   009-3   -   -   -   -   1件:
6 
 17   009-4   -   -   -   -   1件:
6 
 18   009-5   -   -   -   -   1件:
6 
 19   009-a0   -   -   -   -   1件:
6 
 20   009-a1   -   -   -   -   1件:
6 
 21   009-a2   -   -   -   -   1件:
6 
 22   009-a3   -   -   -   -   1件:
6 
 23   1 mg qd to 15 mg qd pf-06649751   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 24   1 mg qd to 7 mg qd pf-06649751 (if de-escalated in parent study)   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 25   1 mg tropicamide   Tropicamide   D00397   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   1件:
6 
 26   1. tesofensine (ns 2330)   Tesofensine   -   -   -   1件:
6 
 27   1.0 mg rasagiline mesylate   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 28   11c-pbr28   -   -   -   -   1件:
6 
 29   11c-raclopride   Raclopride   -   -   -   1件:
6 
 30   15 mg qd de-escalated to 7 mg qd pf-06649751 in parent study remain at 7 mg qd   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 31   15 mg qd pf-06649751   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 32   15o h2o   -   -   -   -   1件:
6 
 33   18-fdtbz   -   -   -   -   1件:
6 
 34   18f florbetaben   -   -   -   -   1件:
6 
 35   18f- dtbz   -   -   -   -   1件:
6 
 36   18f-av-133   Florbenazine f-18   -   -   -   1件:
6 
 37   18f-av-45   -   -   -   -   2件:
6,
127 
 38   18f-dopa   -   -   -   -   2件:
6,
75 
 39   18f-dopa pet   -   -   -   -   1件:
6 
 40   18f-dtbz   -   -   -   -   1件:
6 
 41   18f-dtbz av-133   -   -   -   -   1件:
6 
 42   18f-fdg   Fludeoxyglucose f-18   -   -   -   7件:
6,
13,
46,
53,
84,
127,
300 
 43   1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]-   -   -   -   -   1件:
6 
 44   1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea   -   -   -   -   1件:
6 
 45   1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]-   -   -   -   -   1件:
6 
 46   1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea   -   -   -   -   1件:
6 
 47   2 mg perampanel   Perampanel   D08964   4件: GRIA1, GRIA2, GRIA3, GRIA4   13件: Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Transcriptional misregulation in cancer, cAMP signaling pathway   1件:
6 
 48   200 mg bia 6-512   -   -   -   -   1件:
6 
 49   207-3120   -   -   -   -   1件:
6 
 50   240mg amantadine hcl er tablets   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 51   25330   -   -   -   -   1件:
6 
 52   3 mg qd to 15 mg qd pf-06649751   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 53   3 mg qd to 7 mg qd pf-06649751 (de-escalated in parent study)   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 54   3 mg tropicamide   Tropicamide   D00397   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   1件:
6 
 55   3- (9,10- didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate   -   -   -   -   1件:
6 
 56   320mg amantadine hcl er tablets   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 57   4 mg perampanel   Perampanel   D08964   4件: GRIA1, GRIA2, GRIA3, GRIA4   13件: Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Transcriptional misregulation in cancer, cAMP signaling pathway   1件:
6 
 58   6abeta - apomorphine-10,11-diol hydrochloride hemihydrate   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 59   6aß - apomorphine-10,11-diol hydrochloride hemihydrate   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 60   7 mg qd to 15 mg qd pf-06649751   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 61   7 mg qd to 7 mg qd pf-06649751 (de-escalated in parent study)   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 62   7-beta-hydroxyepiandrosterone   -   -   -   -   1件:
6 
 63   [11c]pbr28   -   -   -   -   1件:
6 
 64   [11c]pxt012253   -   -   -   -   1件:
6 
 65   [11c]smw139   -   -   -   -   1件:
6 
 66   [123i] 5-ia   -   -   -   -   1件:
6 
 67   [123i] ibvm and spect imaging   -   -   -   -   1件:
6 
 68   [123i] mzint injection and serial dynamic spect imaging   -   -   -   -   1件:
6 
 69   [123i]-ibvm   -   -   -   -   1件:
6 
 70   [123i]b-cit   -   -   -   -   1件:
6 
 71   [123i]b-cit spect imaging   -   -   -   -   1件:
6 
 72   [123i]beta cit   -   -   -   -   1件:
6 
 73   [123i]beta cit and spect imaging   -   -   -   -   1件:
6 
 74   [123i]beta-cit   -   -   -   -   1件:
6 
 75   [123i]beta-cit and spect imaging   -   -   -   -   1件:
6 
 76   [123i]clinde   -   -   -   -   2件:
6,
13 
 77   [123i]mni-420   -   -   -   -   2件:
6,
8 
 78   [123i]ß cit   -   -   -   -   1件:
6 
 79   [123i]ß cit and spect imaging   -   -   -   -   1件:
6 
 80   [123i]ß-cit   -   -   -   -   1件:
6 
 81   [123i]ß-cit and spect imaging   -   -   -   -   1件:
6 
 82   [14c]-bia 9-1067   -   -   -   -   1件:
6 
 83   [15o]h2o   -   -   -   -   1件:
6 
 84   [18f] cfpypb   -   -   -   -   1件:
6 
 85   [18f] lbt-999 pet   -   -   -   -   1件:
6 
 86   [18f] pbr06   -   -   -   -   2件:
6,
13 
 87   [18f]-(e)-n-(3-iodoprop-2-enyl)-2b-carbofluoroethoxy-3b-(4'-methylphenyl)nortropane   -   -   -   -   1件:
6 
 88   [18f]-feppa   -   -   -   -   2件:
6,
13 
 89   [18f]dpa-714 pet scan   -   -   -   -   1件:
6 
 90   [18f]fdopa pet/ct   -   -   -   -   1件:
6 
 91   [18f]fe-pe2i   -   -   -   -   1件:
6 
 92   [18f]fpeb   -   -   -   -   3件:
6,
8,
206 
 93   [18f]mk-9470   -   -   -   -   1件:
6 
 94   [18f]mni-1126   -   -   -   -   1件:
6 
 95   [18f]mppf   -   -   -   -   1件:
6 
 96   [18f]nos   -   -   -   -   1件:
6 
 97   [18f]p17-059   -   -   -   -   1件:
6 
 98   [18f]t807 ([18f]mni-777)   -   -   -   -   2件:
5,
6 
 99   Ab1010   Masitinib   D10229   1件: KIT   11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway   6件:
2,
5,
6,
13,
46,
96 
 100   Abbv-0805   -   -   -   -   1件:
6 
 101   Abbv-951   -   -   -   -   1件:
6 
 102   Abt-slv187   -   -   -   -   1件:
6 
 103   Acamprosate   Acamprosate   D02780, D07058   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   2件:
6,
206 
 104   Accordion pill carbidopa/levodopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 105   Accordion pill™ carbidopa/levodopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 106   Accordion pill™ carbidopa/levodopa 50/400 mg   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 107   Accordion pill™ carbidopa/levodopa 50/500 mg   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 108   Acetate   Acetate   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 109   Acetylcysteine   Acetylcysteine   D00221   -   -   14件:
6,
13,
19,
20,
49,
51,
58,
85,
94,
111,
164,
233,
298,
299 
 110   Acp-103   -   -   -   -   1件:
6 
 111   Acr325   Acr325   -   -   -   1件:
6 
 112   Active comparator   -   -   -   -   2件:
6,
46 
 113   Active drug (biib014) at 10, 30, 100, or 300 mg once daily.   Dihydrotachysterol   D00299   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   1件:
6 
 114   Active drug: pimavanserin 17mg (2 strength tablets)   Pimavanserin   -   -   -   1件:
6 
 115   Active investigational treatment ent-01   -   -   -   -   1件:
6 
 116   Ad-810n (zonisamide)   Zonisamide   D00538   8件: CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   11件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus   1件:
6 
 117   Adjuvant without active component   -   -   -   -   2件:
6,
17 
 118   Administration of stable isotope-labelled leucine-   L-leucine   D00030   -   -   1件:
6 
 119   Ads-5102   -   -   -   -   2件:
6,
13 
 120   Ads-5102 (extended release amantadine hcl)   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 121   Adx48621   -   -   -   -   1件:
6 
 122   Affitope® pd01a   -   -   -   -   1件:
6 
 123   Affitope® pd01a + adjuvant   -   -   -   -   2件:
6,
17 
 124   Afq056   -   -   -   -   3件:
6,
8,
206 
 125   Afq056 with l-dopa   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 126   Agomelatine   Agomelatine   D02578   3件: HTR2C, MTNR1A, MTNR1B   6件: Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse   1件:
6 
 127   Agomelatine or piacebo   Agomelatine   D02578   3件: HTR2C, MTNR1A, MTNR1B   6件: Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse   1件:
6 
 128   Allogeneic bone marrow-derived mscs   -   -   -   -   1件:
6 
 129   Allopurinol   Allopurinol   D00224   1件: XDH   5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism   6件:
6,
46,
57,
66,
96,
97 
 130   Altropane   Altropane   -   -   -   1件:
6 
 131   Altropane®   Altropane   -   -   -   1件:
6 
 132   Amantadine   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   4件:
6,
8,
13,
127 
 133   Amantadine 300 mg   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 134   Amantadine hcl er   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 135   Amantadine hcl extended release   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 136   Amantadine hydrochloride   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 137   Amantadine sulfate   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 138   Ambrosan 60mg tablets   -   -   -   -   1件:
6 
 139   Ambroxol   Ambroxol   D07442   -   -   2件:
6,
19 
 140   Ambroxol hydrochloride   Ambroxol   D07442   -   -   1件:
6 
 141   Amoxicillin   Amoxicillin   D00229, D02925, D07452   -   -   6件:
6,
46,
63,
96,
97,
222 
 142   Ampyra first,   -   -   -   -   1件:
6 
 143   Anavex2-73   -   -   -   -   2件:
6,
156 
 144   Anti-parkinson medication   -   -   -   -   4件:
5,
6,
7,
17 
 145   Ap-cd/ld   -   -   -   -   1件:
6 
 146   Ap09004   -   -   -   -   1件:
6 
 147   Apl-130277   -   -   -   -   1件:
6 
 148   Aplindore   Aplindore   -   -   -   1件:
6 
 149   Aplindore mr tablets   Aplindore   -   -   -   1件:
6 
 150   Apo-go   -   -   -   -   1件:
6 
 151   Apo-go®   -   -   -   -   1件:
6 
 152   Apokinon   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 153   Apokyn   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 154   Apomorphine   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 155   Apomorphine 0.25% (2.5mg/ml)   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 156   Apomorphine hcl injection   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 157   Apomorphine hydrochloride   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 158   Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 159   Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 160   Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 161   Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 162   Apomorphine hydrocloride   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 163   Apomorphine hydrocloride hemihydrate   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 164   Apomorphine infusion   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 165   Apomorphine nasal powder   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 166   Aqw051   -   -   -   -   1件:
6 
 167   Aricept   Donepezil   D00670, D07869   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   4件:
6,
13,
78,
124 
 168   Aricept 5 mg-filmtabletten   -   -   -   -   1件:
6 
 169   Aricept 5mg-filmtabletten   -   -   -   -   1件:
6 
 170   Aripiprazole   Aripiprazole   D01164   4件: DRD2, DRD3, HTR1A, HTR2A   12件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway   2件:
6,
206 
 171   Armodafinil   Armodafinil   D03215   1件: SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   3件:
6,
13,
84 
 172   At 10   Dihydrotachysterol   D00299   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   1件:
6 
 173   Atm fog in pd   -   -   -   -   1件:
6 
 174   Atomoxetine   Atomoxetine   D02574, D07473   1件: SLC6A2   1件: Synaptic vesicle cycle   3件:
6,
8,
13 
 175   Atypical antipsychotics   -   -   -   -   1件:
6 
 176   Autologous mesenchymal stem cells   -   -   -   -   5件:
2,
6,
13,
17,
46 
 177   Av-101   -   -   -   -   1件:
6 
 178   Avalox   Moxifloxacin   D00874, D08237   -   -   1件:
6 
 179   Avalox - 400 mg compresse rivestite con film 5 compresse in blister pp/al   Moxifloxacin   D00874, D08237   -   -   1件:
6 
 180   Ave8112   -   -   -   -   1件:
6 
 181   Avp-923   -   -   -   -   3件:
2,
6,
13 
 182   Avp-923-45   -   -   -   -   1件:
6 
 183   Azd3241   -   -   -   -   2件:
6,
17 
 184   Azd3241 300 mg bid   -   -   -   -   1件:
6 
 185   Azd3241 600 mg bid   -   -   -   -   1件:
6 
 186   Azd3241 alternative titration scheme with formulation 1 or 2   -   -   -   -   1件:
6 
 187   Azd3241 er formulation 1   -   -   -   -   1件:
6 
 188   Azd3241 extended release tablets 100 mg   -   -   -   -   1件:
6 
 189   Azd3241 extended release tablets 25 mg   -   -   -   -   1件:
6 
 190   Azilect   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   3件:
5,
6,
17 
 191   Azilect®   -   -   -   -   1件:
6 
 192   B-cit and spect imaging   -   -   -   -   1件:
6 
 193   B6, b12, l-methylfolate   Levomefolic acid   D09353   -   -   1件:
6 
 194   Balance   Isoxaflutole   -   -   -   8件:
5,
6,
13,
18,
81,
113,
149,
299 
 195   Bavisant   Bavisant   D09870   1件: HRH3   1件: Neuroactive ligand-receptor interaction   1件:
6 
 196   Bavisant dihydrochloride monohydrate   Bavisant   D09870   1件: HRH3   1件: Neuroactive ligand-receptor interaction   1件:
6 
 197   Bavisant hydrochloride monohydrate   Bavisant   D09870   1件: HRH3   1件: Neuroactive ligand-receptor interaction   1件:
6 
 198   Bee venom   -   -   -   -   1件:
6 
 199   Ben-2001   -   -   -   -   1件:
6 
 200   Benserazide   Benserazide   D03082   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 201   Benserazide hydrochloride   Benserazide   D03082   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 202   Benzofuran   Benzofuran   -   -   -   1件:
6 
 203   Best medical treatment   -   -   -   -   1件:
6 
 204   Bf 2.649   -   -   -   -   1件:
6 
 205   Bf2.649   -   -   -   -   1件:
6 
 206   Bf2.649 (pitolisant)   Pitolisant   D10749   1件: HRH3   1件: Neuroactive ligand-receptor interaction   1件:
6 
 207   Bi-sifrol®   -   -   -   -   1件:
6 
 208   Bia 3-202   -   -   -   -   1件:
6 
 209   Bia 3-202 (200 mg)   -   -   -   -   1件:
6 
 210   Bia 6-512   -   -   -   -   1件:
6 
 211   Bia 6-512 100 mg   -   -   -   -   1件:
6 
 212   Bia 6-512 100 mg dose   -   -   -   -   1件:
6 
 213   Bia 6-512 200 mg dose   -   -   -   -   1件:
6 
 214   Bia 6-512 25 mg   -   -   -   -   1件:
6 
 215   Bia 6-512 25 mg dose   -   -   -   -   1件:
6 
 216   Bia 6-512 400 mg   -   -   -   -   1件:
6 
 217   Bia 6-512 50 mg dose   -   -   -   -   1件:
6 
 218   Bia 9-1067   -   -   -   -   1件:
6 
 219   Bia 9-1067 (test)   -   -   -   -   1件:
6 
 220   Bia 9-1067 15 mg   -   -   -   -   1件:
6 
 221   Bia 9-1067 25 mg   -   -   -   -   1件:
6 
 222   Bia 9-1067 30 mg   -   -   -   -   1件:
6 
 223   Bia 9-1067 5 mg   -   -   -   -   1件:
6 
 224   Bia 9-1067 micronized   -   -   -   -   1件:
6 
 225   Bia 9-1067 non-micronized   -   -   -   -   1件:
6 
 226   Biib014   -   -   -   -   1件:
6 
 227   Biib054   -   -   -   -   1件:
6 
 228   Biib094   -   -   -   -   1件:
6 
 229   Bisphosphonates   -   -   -   -   2件:
6,
274 
 230   Bone marrow derived mesenchymal stem cells   -   -   -   -   2件:
6,
60 
 231   Bont-a   -   -   -   -   1件:
6 
 232   Botox   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   4件:
6,
13,
149,
226 
 233   Botulinum toxin   -   -   -   -   1件:
6 
 234   Botulinum toxin type a   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   10件:
2,
5,
6,
7,
13,
15,
17,
70,
113,
149 
 235   Botulinum toxin type b   Botulinum toxin type b   D02735   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   3件:
2,
6,
51 
 236   Botulinum toxin type b (myobloc)   Botulinum toxin type b   D02735   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   2件:
2,
6 
 237   Botulinum toxin: xeomin   -   -   -   -   1件:
6 
 238   Bromocriptine   Bromocriptine   D00780, D03165   2件: DRD2, PRL   12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   2件:
6,
74 
 239   Bromocriptine and other dopamine agonists   Bromocriptine   D00780, D03165   2件: DRD2, PRL   12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 240   Btrx-246040   -   -   -   -   1件:
6 
 241   Btx-a   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   1件:
6 
 242   Bumetanide   Bumetanide   D00247   1件: SLC12A2   3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection   2件:
6,
158 
 243   Bumetanide white, oblong, scored tablet   Bumetanide   D00247   1件: SLC12A2   3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection   1件:
6 
 244   Bupleurum+ginkgo   Ginkgo biloba   -   -   -   1件:
6 
 245   Buspirone   Buspirone   D00702, D07593   2件: DRD2, HTR1A   10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway   2件:
6,
51 
 246   Buspirone hydrochloride   Buspirone   D00702, D07593   2件: DRD2, HTR1A   10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway   1件:
6 
 247   Butylphthalide   Butylphthalide   -   -   -   2件:
2,
6 
 248   Byetta 5 micrograms   Exenatide   D04121   1件: GLP1R   3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
6 
 249   Cabaseril   Cabergoline   D00987   2件: DRD2, PRL   12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 250   Cabaseril, 1,0 mg tablette   Cabergoline   D00987   2件: DRD2, PRL   12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 251   Cabaseril, 2,0 mg tablette   Cabergoline   D00987   2件: DRD2, PRL   12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 252   Cabergoline   Cabergoline   D00987   2件: DRD2, PRL   12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   3件:
6,
74,
75 
 253   Caffeine   Caffeine   D00528, D01453   11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A   22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   6件:
2,
6,
46,
78,
96,
97 
 254   Caffeine 100-200 mg bid   Caffeine   D00528, D01453   11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A   22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 255   Caffeine alkaloid   Caffeine   D00528, D01453   11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A   22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 256   Calcium   Calcium   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299 
 257   Cannabidiol   Cannabidiol   D10915   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   13件:
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271 
 258   Cannabis   Medical cannabis   -   -   -   6件:
2,
6,
13,
90,
96,
97 
 259   Cannabis oil   Medical cannabis   -   -   -   1件:
6 
 260   Cannabis, medical   Medical cannabis   -   -   -   5件:
2,
6,
13,
96,
97 
 261   Capsaicin   Capsaicin   D00250   1件: TRPV1   2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   6件:
2,
6,
19,
86,
113,
226 
 262   Capsaicin vapor   Capsaicin   D00250   1件: TRPV1   2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   1件:
6 
 263   Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg)   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 264   Capture   Bifenthrin   -   -   -   2件:
6,
46 
 265   Carbidopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   8件:
2,
4,
6,
13,
17,
90,
164,
201 
 266   Carbidopa 20 mg   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 267   Carbidopa 27.5 mg   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 268   Carbidopa 65 mg capsule   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 269   Carbidopa and levodopa 25mg/100mg   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 270   Carbidopa fu   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 271   Carbidopa levodopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 272   Carbidopa monohydrate   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 273   Carbidopa, levodopa, entacapone   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 274   Carbidopa- levodopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 275   Carbidopa-levodopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   3件:
2,
4,
6 
 276   Carbidopa/l-dopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 277   Carbidopa/l-dopa/entacapone   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 278   Carbidopa/levodopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 279   Carbidopa/levodopa, immediate release   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 280   Carbidopa/levodopa/entacapone   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 281   Carbon   Activated charcoal   D03251   -   -   7件:
6,
46,
85,
86,
96,
97,
298 
 282   Carnosine   Carnosine   -   -   -   2件:
6,
13 
 283   Carnosine supplementation   Carnosine   -   -   -   1件:
6 
 284   Carvedilol   Carvedilol   D00255, D03415   5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2   12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   4件:
6,
57,
86,
113 
 285   Catapres ampoules   Clonidine   D00281, D00604   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   1件:
6 
 286   Cd-ld cr   -   -   -   -   1件:
6 
 287   Cd-ld ir   -   -   -   -   1件:
6 
 288   Cdnf   -   -   -   -   1件:
6 
 289   Ceftriaxone   Ceftriaxone   D00924, D07659   -   -   3件:
2,
6,
97 
 290   Cep-1347   -   -   -   -   1件:
6 
 291   Cep-1347 10mg   -   -   -   -   1件:
6 
 292   Cep-1347 50mg   -   -   -   -   1件:
6 
 293   Cep1347   Cep1347   -   -   -   1件:
6 
 294   Cep1347 25mg   Cep1347   -   -   -   1件:
6 
 295   Cere-120   -   -   -   -   1件:
6 
 296   Cere-120: adeno-associated virus delivery of neurturin   -   -   -   -   1件:
6 
 297   Cerebral dopamine neurotrophic factor   Dopamine   D00633, D07870   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 298   Ceretec   Technetium tc-99m exametazime   D02284   -   -   1件:
6 
 299   Ceretec (tm) estabilizado   Technetium tc-99m exametazime   D02284   -   -   1件:
6 
 300   Champix   Varenicline   D08669   2件: CHRNA4, CHRNB2   3件: Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   1件:
6 
 301   Chloride   Chloride ion   -   -   -   17件:
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299 
 302   Chocolate   Cocoa   -   -   -   1件:
6 
 303   Cipralex   -   -   -   -   1件:
6 
 304   Cjh1 (clr4001)   -   -   -   -   1件:
6 
 305   Clarithromycin   Clarithromycin   D00276   -   -   8件:
6,
63,
84,
96,
97,
222,
228,
299 
 306   Clarium   Loratadine   D00364   1件: HRH1   3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   1件:
6 
 307   Clarium 50 mg retardtabletten   Loratadine   D00364   1件: HRH1   3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   1件:
6 
 308   Clartihromycin, amoxicillin, and omeprazole   Amoxicillin   D00229, D02925, D07452   -   -   1件:
6 
 309   Clonazepam   Clonazepam   D00280   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   1件:
6 
 310   Clonidine   Clonidine   D00281, D00604   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   2件:
6,
78 
 311   Clonidine hydrochloride   Clonidine   D00281, D00604   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   2件:
6,
78 
 312   Clozapine   Clozapine   D00283   11件: ADRA2A, ADRA2B, ADRA2C, DRD4, HTR2A, HTR2C, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E   8件: Calcium signaling pathway, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway   1件:
6 
 313   Cocoa   Cocoa   -   -   -   1件:
6 
 314   Coenzyme q10   Ubidecarenone   D01065   -   -   10件:
2,
6,
8,
10,
46,
57,
113,
193,
214,
215 
 315   Coenzyme q10 nanodispersion (nanoquinone)   Ubidecarenone   D01065   -   -   1件:
6 
 316   Coenzyme q10 with vitamin e   Vitamin e   D02331   -   -   1件:
6 
 317   Cogane™ (pym50028)   -   -   -   -   1件:
6 
 318   Cohort 1:nilotinib oral capsules (150mg or 300mg)   Nilotinib   D08953   4件: ABL1, KIT, PDGFRA, PDGFRB   33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Viral myocarditis   1件:
6 
 319   Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1)   Nilotinib   D08953   4件: ABL1, KIT, PDGFRA, PDGFRB   33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Viral myocarditis   1件:
6 
 320   Combination injection of epo and g-csf   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   1件:
6 
 321   Comparator: carbidopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 322   Comparator: levodopa   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 323   Comtan   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 324   Comtan®   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 325   Comtess   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 326   Comtess®   -   -   -   -   1件:
6 
 327   Continuous intrajejunal infusion of levodopa-carbidopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 328   Continuous release dopamine agonists   Dopamine   D00633, D07870   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 329   Control   Chloroxylenol   D03473   -   -   4件:
6,
13,
46,
168 
 330   Controlled-release levodopa / carbidopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 331   Coq10   Ubidecarenone   D01065   -   -   3件:
5,
6,
8 
 332   Creatine   Creatine   -   -   -   12件:
1,
2,
5,
6,
8,
13,
46,
49,
50,
113,
156,
201 
 333   Cu(ii)atsm   -   -   -   -   2件:
2,
6 
 334   Cvd00118-e   -   -   -   -   1件:
6 
 335   Cvt-301   -   -   -   -   1件:
6 
 336   Cvt-301 (dose level 1)   -   -   -   -   1件:
6 
 337   Cvt-301 (dose level 2)   -   -   -   -   1件:
6 
 338   Cvt-301 35mg   -   -   -   -   1件:
6 
 339   Cvt-301 50mg   -   -   -   -   1件:
6 
 340   Cvt-301 high dose   -   -   -   -   1件:
6 
 341   Cvt-301 low dose   -   -   -   -   1件:
6 
 342   Cvt-301, lip   -   -   -   -   1件:
6 
 343   Cvxl-0107   -   -   -   -   1件:
6 
 344   Cx-8998   -   -   -   -   1件:
6 
 345   Cyberknife   -   -   -   -   1件:
6 
 346   Cymbalta   Duloxetine   D01179, D07880   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
6,
13,
49 
 347   Cysteine   L-cysteine   D00026, D02326   -   -   9件:
6,
13,
19,
84,
85,
88,
90,
254,
296 
 348   Cystoscopic injection of botox into the urinary bladder   -   -   -   -   1件:
6 
 349   D-serine   Serine   D00016   -   -   1件:
6 
 350   D-serine (~2g/day)   Serine   D00016   -   -   1件:
6 
 351   Da-9701   -   -   -   -   1件:
6 
 352   Da-9805 45mg   -   -   -   -   1件:
6 
 353   Da-9805 90mg   -   -   -   -   1件:
6 
 354   Dacepton 5 mg/ml   -   -   -   -   1件:
6 
 355   Dacepton 5 mg/ml infuusioneste, liuos   -   -   -   -   1件:
6 
 356   Darifenacin   Darifenacin   D01699, D03654   1件: CHRM3   9件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction   2件:
6,
13 
 357   Dark chocolate (85% cocoa)   Cocoa   -   -   -   1件:
6 
 358   Date   Date   -   -   -   3件:
6,
88,
113 
 359   Datscan   Ioflupane i-123   D10014   -   -   3件:
2,
5,
6 
 360   Datscan™   -   -   -   -   1件:
6 
 361   Dc158am   -   -   -   -   1件:
6 
 362   Deanol   Deanol   D07777   -   -   1件:
6 
 363   Deanol pyroglutamate   Deanol   D07777   -   -   1件:
6 
 364   Debrumyl   -   -   -   -   1件:
6 
 365   Deferiprone   Deferiprone   D07416   -   -   5件:
2,
6,
120,
122,
233 
 366   Deferiprone (ferriprox)   Deferiprone   D07416   -   -   1件:
6 
 367   Deferiprone 600 mg delayed release tablet   Deferiprone   D07416   -   -   1件:
6 
 368   Desmopressin   Desmopressin   D00291, D02235   2件: AVPR2, F8   4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption   5件:
6,
64,
72,
225,
288 
 369   Desmopressin acetat   Desmopressin   D00291, D02235   2件: AVPR2, F8   4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption   1件:
6 
 370   Desmotabs   -   -   -   -   1件:
6 
 371   Desmotabs® 0,2 mg tabletten   -   -   -   -   1件:
6 
 372   Desmotabs® 0,2mg tabletten   -   -   -   -   1件:
6 
 373   Dexdor   -   -   -   -   4件:
2,
4,
6,
70 
 374   Dexmedetomidina   Dexmedetomidine   D00514, D01205   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   1件:
6 
 375   Dexmedetomidine   Dexmedetomidine   D00514, D01205   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   11件:
2,
4,
6,
21,
34,
70,
113,
212,
215,
226,
280 
 376   Dexmedetomidine hydrochloride infusion   Dexmedetomidine   D00514, D01205   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   1件:
6 
 377   Dextromethorphan   Dextromethorphan   D00848, D03742, D03744   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   9件:
2,
6,
8,
13,
46,
78,
96,
97,
156 
 378   Different diets   -   -   -   -   1件:
6 
 379   Dihydroergotoxine mesylate   Ergoloid mesylate   D02268   6件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C   7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
6 
 380   Dipivefrin   Dipivefrin   D02349   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 381   Dipivefrine   Dipivefrin   D02349   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 382   Dipraglurant   Dipraglurant   -   -   -   1件:
6 
 383   Ditropan elixir   Oxybutynin   D00465, D00722   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   1件:
6 
 384   Dm-1992   -   -   -   -   1件:
6 
 385   Dnl151 high dose   -   -   -   -   1件:
6 
 386   Dnl151 low dose   -   -   -   -   1件:
6 
 387   Dnl201 high dose   -   -   -   -   1件:
6 
 388   Dnl201 low dose   -   -   -   -   1件:
6 
 389   Dns-7801 (high dose)   -   -   -   -   1件:
6 
 390   Dns-7801 (low-dose)   -   -   -   -   1件:
6 
 391   Docosahexaenoic acid   Doconexent   -   -   -   7件:
6,
49,
90,
94,
240,
299,
301 
 392   Docosahexaenoic acid (dha)   Doconexent   -   -   -   3件:
6,
94,
299 
 393   Domperidone   Domperidone   D01745, D07868   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   5件:
6,
13,
17,
51,
230 
 394   Domperidone (drug)   Domperidone   D01745, D07868   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 395   Dompéridone   -   -   -   -   1件:
6 
 396   Donepezil   Donepezil   D00670, D07869   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   9件:
5,
6,
13,
46,
78,
124,
127,
156,
206 
 397   Donepezil sandoz   Donepezil   D00670, D07869   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
6 
 398   Dopamine   Dopamine   D00633, D07870   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   3件:
6,
7,
74 
 399   Dopamine agent   Dopamine   D00633, D07870   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 400   Dopamine agonists (pramipexole, ropirinole)   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 401   Dopaminergic agonist + apomorphine   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 402   Dopaminergic agonists   -   -   -   -   1件:
6 
 403   Dops   Droxidopa   D01277   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   2件:
6,
17 
 404   Doxepin   Doxepin   D00814, D07875   3件: HRH1, SLC6A2, SLC6A4   5件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle   1件:
6 
 405   Doxepin and zopiclone   Zopiclone   D01372   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   1件:
6 
 406   Dpa-714-pet/mri   -   -   -   -   1件:
6 
 407   Droxidopa   Droxidopa   D01277   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   3件:
5,
6,
17 
 408   Duloxetine   Duloxetine   D01179, D07880   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   2件:
6,
13 
 409   Duloxetine hydrochloride   Duloxetine   D01179, D07880   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   1件:
6 
 410   Duodopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 411   Duodopa intestinal gel   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 412   Duodopa ld/cd 20/5 mg/ml   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 413   Dynacirc cr (isradipine)   Isradipine   D00349   4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S   34件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 414   E2007   -   -   -   -   2件:
6,
144 
 415   Ebixa   Memantine   D04905, D08174   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   3件:
2,
6,
13 
 416   Ebixa®   -   -   -   -   1件:
6 
 417   Egcg   Epigallocatechin gallate   -   -   -   8件:
6,
13,
17,
28,
85,
113,
206,
299 
 418   Elc200   -   -   -   -   1件:
6 
 419   Eliprodil   Eliprodil   -   -   -   1件:
6 
 420   Eltoprazine   Eltoprazine   -   -   -   1件:
6 
 421   Eltoprazine hcl   Eltoprazine   -   -   -   1件:
6 
 422   Eltoprazine hydrochloride   Eltoprazine   -   -   -   1件:
6 
 423   Emd 128130   -   -   -   -   2件:
6,
156 
 424   Emd128130   -   -   -   -   1件:
6 
 425   Ent-01   -   -   -   -   1件:
6 
 426   Entacapon   -   -   -   -   1件:
6 
 427   Entacapona   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 428   Entacapone   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   2件:
6,
17 
 429   Entacapone and carbidopa   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 430   Epi-589   -   -   -   -   2件:
2,
6 
 431   Epi-743 200mg   -   -   -   -   1件:
6 
 432   Epi-743 400mg   -   -   -   -   1件:
6 
 433   Er cd-ld   -   -   -   -   1件:
6 
 434   Er tablet 100 mg azd3241   -   -   -   -   1件:
6 
 435   Er tablet 25 mg azd3241   -   -   -   -   1件:
6 
 436   Eradication of helcobacter pylori   -   -   -   -   1件:
6 
 437   Eradication therapy for h.pylori infection   -   -   -   -   1件:
6 
 438   Eradication therapy for helicobacter pylori   -   -   -   -   1件:
6 
 439   Erythromycin   Erythromycin   D00140, D00851, D01361, D02009, D02184, D02523, D02524, D02525, D04054   -   -   5件:
6,
36,
164,
228,
291 
 440   Erythropoietin   Erythropoietin   D03231   1件: EPOR   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   8件:
2,
6,
13,
22,
47,
70,
95,
96 
 441   Erythropoietin human recombinant (eporh)   Erythropoietin   D03231   1件: EPOR   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   1件:
6 
 442   Escitalopram   Escitalopram   D02567, D07704, D07913   1件: SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
2,
6,
13 
 443   Esomeprazole   Esomeprazole   D01984, D04056, D07917, D09339   2件: ATP4A, ATP4B   4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation   6件:
6,
46,
86,
98,
298,
299 
 444   Eszopiclone   Eszopiclone   D02624   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   3件:
6,
13,
46 
 445   Ethnodyne visio   -   -   -   -   1件:
6 
 446   Exametazime   Exametazime   D01109   -   -   1件:
6 
 447   Exelon   Rivastigmine   D02558, D03822   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   2件:
6,
13 
 448   Exelon 4.6 mg/24 h transdermal patch   Rivastigmine   D02558, D03822   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
6 
 449   Exelon 9.5 mg/24 h transdermal patch   Rivastigmine   D02558, D03822   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
6 
 450   Exelon patch (rivastigmine transdermal system)   Rivastigmine   D02558, D03822   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
6 
 451   Exenatide   Exenatide   D04121   1件: GLP1R   3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   3件:
6,
193,
233 
 452   Exenatide 10 micrograms   Exenatide   D04121   1件: GLP1R   3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
6 
 453   Exenatide 5 micrograms   Exenatide   D04121   1件: GLP1R   3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
6 
 454   F-18 fpcit   -   -   -   -   1件:
6 
 455   Famotidine   Famotidine   D00318   1件: HRH2   3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction   3件:
6,
46,
86 
 456   Febuxostat   Febuxostat   D01206   1件: XDH   5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism   3件:
2,
6,
13 
 457   Ferrprox (deferiprone)   Deferiprone   D07416   -   -   1件:
6 
 458   Fesoterodine   Fesoterodine   D07226   2件: CHRM2, CHRM3   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   1件:
6 
 459   Fetal porcine cells, neurocell-pd   -   -   -   -   1件:
6 
 460   Filgrastim   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   25件:
2,
6,
13,
25,
26,
28,
34,
35,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
96,
113,
164,
283,
284,
285,
331 
 461   Finasteride   Finasteride   D00321   1件: SRD5A2   2件: Prostate cancer, Steroid hormone biosynthesis   1件:
6 
 462   Fipamezole   Fipamezole   -   -   -   2件:
6,
17 
 463   Fipamezole hydrochloride   Fipamezole   -   -   -   2件:
6,
17 
 464   Fipamezole hydrochloride 30 mg oral disintegrating tablets   Fipamezole   -   -   -   2件:
6,
17 
 465   Fipamezole hydrochloride 60 mg oral disintegrating tablets   Fipamezole   -   -   -   2件:
6,
17 
 466   Fipamezole hydrochloride 90 mg oral disintegrating tablets   Fipamezole   -   -   -   2件:
6,
17 
 467   Fipamezole odt   Fipamezole   -   -   -   1件:
6 
 468   Fipamezole odt cohort 2   Fipamezole   -   -   -   1件:
6 
 469   Flecainide   Flecainide   D00638, D07962   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   1件:
6 
 470   Flecainide acetate   Flecainide   D00638, D07962   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   1件:
6 
 471   Flecainidum   Flecainide   D00638, D07962   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   1件:
6 
 472   Florbetaben (18f)   -   -   -   -   1件:
6 
 473   Florbetapir f 18   -   -   -   -   1件:
6 
 474   Fludrocortisone   Fludrocortisone   D00986, D07967   1件: NR3C2   1件: Aldosterone-regulated sodium reabsorption   3件:
6,
17,
81 
 475   Flumazenil   Flumazenil   D00697   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   5件:
6,
13,
17,
18,
206 
 476   Flutemetamol   Flutemetamol   -   -   -   5件:
5,
6,
7,
17,
127 
 477   Folic acid   Folic acid   D00070   -   -   4件:
6,
46,
49,
84 
 478   Folic acid, vitamin b6, vitamin b12   Folic acid   D00070   -   -   1件:
6 
 479   Foliglurax   Foliglurax   -   -   -   1件:
6 
 480   Fpf1100nw   -   -   -   -   1件:
6 
 481   Fpfs-1169   -   -   -   -   1件:
6 
 482   Fursultiamine   Fursultiamine   D03319   -   -   1件:
6 
 483   G-csf   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   12件:
6,
13,
16,
49,
51,
60,
65,
85,
96,
284,
285,
331 
 484   Gabapentin   Gabapentin   D00332   5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), GABAergic synapse, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle   5件:
6,
13,
19,
70,
298 
 485   Gabapentina   Gabapentin   D00332   5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), GABAergic synapse, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle   1件:
6 
 486   Gabapentina kern pharma   Gabapentin   D00332   5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), GABAergic synapse, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle   1件:
6 
 487   Galantamine   Galantamine   D02173, D04292   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   2件:
6,
127 
 488   Ganoderma   -   -   -   -   1件:
6 
 489   Ghrelin   Lenomorelin   -   -   -   3件:
6,
78,
299 
 490   Ginkgo   Ginkgo biloba   -   -   -   3件:
6,
13,
90 
 491   Glial cell line-derived neurotrophic factor   -   -   -   -   1件:
6 
 492   Glial cell line-derived neurotrophic factor (gdnf)   -   -   -   -   1件:
6 
 493   Glucose   D-glucose   D00009   -   -   3件:
6,
13,
299 
 494   Glutathione   Glutathione   D00014, D00031   -   -   2件:
6,
299 
 495   Glycerol   Glycerin   D00028   -   -   4件:
6,
13,
316,
317 
 496   Glycerol phenylbutyrate   Glycerol phenylbutyrate   D10127   -   -   1件:
6 
 497   Glycopyrrolate   Glycopyrronium   D00540, D10938   1件: CHRM3   9件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction   1件:
6 
 498   Gm1 ganglioside   -   -   -   -   1件:
6 
 499   Gm608   -   -   -   -   1件:
6 
 500   Gold   Gold   -   -   -   5件:
2,
6,
13,
46,
171 
 501   Gold nanocrystals   Gold   -   -   -   3件:
2,
6,
13 
 502   Gpi 1485   -   -   -   -   1件:
6 
 503   Grapefruit   Grapefruit   -   -   -   5件:
6,
46,
50,
83,
97 
 504   Green tea   Green tea leaf   D06903   -   -   5件:
6,
17,
28,
46,
96 
 505   Green tea polyphenols (egcg/ecg)   Green tea leaf   D06903   -   -   1件:
6 
 506   Grf6021   -   -   -   -   1件:
6 
 507   Group ad anti-pd + antidepressant   -   -   -   -   1件:
6 
 508   Group r rasagiline   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 509   Group r+ad rasagiline + antidepressant   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 510   Gsk962040   -   -   -   -   1件:
6 
 511   Gsk962040 (25 mg tablet)   -   -   -   -   1件:
6 
 512   Gz/sar402671   -   -   -   -   2件:
6,
19 
 513   Hb-admsc   -   -   -   -   2件:
6,
46 
 514   Helicobacter pylori eradication therapy   -   -   -   -   1件:
6 
 515   Heptaminol   Heptaminol   D07158   -   -   1件:
6 
 516   Heptaminol hydrochloride   Heptaminol   D07158   -   -   1件:
6 
 517   Herbal medicinal mixture (roucongrong, heshouwu etc.)   Reynoutria multiflora root   -   -   -   1件:
6 
 518   Heshouwu   Reynoutria multiflora root   -   -   -   1件:
6 
 519   Hf0220   -   -   -   -   1件:
6 
 520   High dose affitope® pd03a + adjuvant   -   -   -   -   1件:
6 
 521   High dose anavex2-73   -   -   -   -   1件:
6 
 522   High protein. t-diet plus range   -   -   -   -   1件:
6 
 523   Hp-3000 (ropinirole hydrochloride patch)   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 524   Hp-3000 placebo   -   -   -   -   1件:
6 
 525   Hp-3000(ropinirole hydrochloride patch)   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 526   Human neural stem cell   -   -   -   -   1件:
6 
 527   Human stem cells   -   -   -   -   1件:
6 
 528   Hydrocortisone   Hydrocortisone   D00088   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   8件:
6,
53,
75,
78,
81,
83,
97,
299 
 529   Hydrocortisone cream   Hydrocortisone   D00088   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
6 
 530   Hydrocortisone cream 1%   Hydrocortisone   D00088   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
6 
 531   Hydrocortisone cream 10mg/g fna fagron   Hydrocortisone   D00088   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
6 
 532   Hydrogen   Hydrogen   -   -   -   5件:
5,
6,
17,
97,
226 
 533   I 123   Iodide i-123   -   -   -   1件:
6 
 534   I-123   Iodide i-123   -   -   -   2件:
2,
6 
 535   I-123-5-ia85380   Iodide i-123   -   -   -   1件:
6 
 536   Iberogast   -   -   -   -   1件:
6 
 537   Idebenone   Idebenone   D01750   -   -   4件:
6,
13,
113,
302 
 538   Immediate release carbidopa/levodopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 539   Immediate release carbidopa/levodopa 25/100 mg   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 540   Impact   Topramezone   -   -   -   7件:
6,
13,
46,
50,
96,
97,
299 
 541   Incobotulinum toxin a   -   -   -   -   2件:
2,
6 
 542   Incobotulinumtoxina   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   1件:
6 
 543   Infudopa i.v.   -   -   -   -   1件:
6 
 544   Infudopa s.c.   -   -   -   -   1件:
6 
 545   Infusions of young plasma   -   -   -   -   1件:
6 
 546   Inhaled vr040   -   -   -   -   1件:
6 
 547   Injection of apomorphine   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 548   Injection of normal saline   -   -   -   -   1件:
6 
 549   Injection of umbilical cord derived mscs   -   -   -   -   1件:
6 
 550   Inosine   Inosine   D00054   -   -   4件:
2,
6,
13,
17 
 551   Intracerebral microinjections   -   -   -   -   1件:
6 
 552   Intranasal glutathione - (in)gsh   Glutathione   D00014, D00031   -   -   1件:
6 
 553   Intranasal insulin   -   -   -   -   2件:
6,
17 
 554   Intravenous and oral n—acetyl cysteine   L-cysteine   D00026, D02326   -   -   1件:
6 
 555   Intravenous infusion   -   -   -   -   1件:
6 
 556   Intravenous levodopa   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 557   Intravesical injection of botulinum a toxin   -   -   -   -   2件:
6,
17 
 558   Ioflupane (123i)   Ioflupane i-123   D10014   -   -   1件:
6 
 559   Ioflupane 123i (datscan®)   -   -   -   -   1件:
6 
 560   Ioflupane [123 i]   Ioflupane i-123   D10014   -   -   1件:
6 
 561   Ioflupane i 123   Ioflupane i-123   D10014   -   -   1件:
6 
 562   Ipratropium   Ipratropium   D02212   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   2件:
6,
86 
 563   Ipratropium bromide (drug)   Ipratropium   D02212   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   1件:
6 
 564   Iproniazid   Iproniazid   D02579   2件: MAOA, MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 565   Ips-nsc cells   -   -   -   -   1件:
6 
 566   Ipt803   -   -   -   -   1件:
6 
 567   Ipx054 100 mg   -   -   -   -   1件:
6 
 568   Ipx054 150 mg   -   -   -   -   1件:
6 
 569   Ipx054 200 mg   -   -   -   -   1件:
6 
 570   Ipx054 250 mg   -   -   -   -   1件:
6 
 571   Ipx054 300 mg   -   -   -   -   1件:
6 
 572   Ipx066   -   -   -   -   1件:
6 
 573   Ipx066 145 mg   -   -   -   -   1件:
6 
 574   Ipx066 145 mg ld   -   -   -   -   1件:
6 
 575   Ipx066 195 mg   -   -   -   -   1件:
6 
 576   Ipx066 195 mg ld   -   -   -   -   1件:
6 
 577   Ipx066 245 mg   -   -   -   -   1件:
6 
 578   Ipx066 245 mg ld   -   -   -   -   1件:
6 
 579   Ipx066 95 mg   -   -   -   -   1件:
6 
 580   Ipx066 95 mg ld   -   -   -   -   1件:
6 
 581   Ipx066-145   -   -   -   -   1件:
6 
 582   Ipx066-195   -   -   -   -   1件:
6 
 583   Ipx066-245   -   -   -   -   1件:
6 
 584   Ipx066-95   -   -   -   -   1件:
6 
 585   Ipx203 140 mg   -   -   -   -   1件:
6 
 586   Ipx203 180 mg   -   -   -   -   1件:
6 
 587   Ipx203 210 mg   -   -   -   -   1件:
6 
 588   Ipx203 270 mg   -   -   -   -   1件:
6 
 589   Ipx203 280 mg   -   -   -   -   1件:
6 
 590   Ipx203 350 mg   -   -   -   -   1件:
6 
 591   Ipx203 er cd-ld   -   -   -   -   1件:
6 
 592   Ir cd-ld   -   -   -   -   1件:
6 
 593   Irl752   -   -   -   -   1件:
6 
 594   Irl790   -   -   -   -   1件:
6 
 595   Irx4204   -   -   -   -   1件:
6 
 596   Isc-hpnsc   -   -   -   -   1件:
6 
 597   Isicom   -   -   -   -   1件:
6 
 598   Isoflurane   Isoflurane   D00545   -   -   1件:
6 
 599   Isradipine   Isradipine   D00349   4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S   34件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 600   Isradipine cr 10mg   Isradipine   D00349   4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S   34件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 601   Isradipine cr 20mg   Isradipine   D00349   4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S   34件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 602   Isradipine cr 5mg   Isradipine   D00349   4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S   34件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 603   Istradefylline   Istradefylline   D04641   1件: ADORA2A   7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   1件:
6 
 604   Istradefylline ( kw-6002)   Istradefylline   D04641   1件: ADORA2A   7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   1件:
6 
 605   Istradefylline (kw-6002)   Istradefylline   D04641   1件: ADORA2A   7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   1件:
6 
 606   Istradefylline 20 mg   Istradefylline   D04641   1件: ADORA2A   7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   1件:
6 
 607   Istradefylline 20 mg or 40 mg   Istradefylline   D04641   1件: ADORA2A   7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   1件:
6 
 608   Istradefylline 40 mg   Istradefylline   D04641   1件: ADORA2A   7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   1件:
6 
 609   Iti-214   -   -   -   -   1件:
6 
 610   Iv apomorphine   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 611   Iv levodopa   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 612   Jm-010   -   -   -   -   1件:
6 
 613   Jm-010 a group   -   -   -   -   1件:
6 
 614   Jm-010 b group   -   -   -   -   1件:
6 
 615   Jnj-31001074   -   -   -   -   1件:
6 
 616   Jp 1730   -   -   -   -   1件:
6 
 617   Jp-1730/f01   -   -   -   -   2件:
6,
17 
 618   Jp-1730/f02   -   -   -   -   2件:
6,
17 
 619   Jp-1730/f03   -   -   -   -   2件:
6,
17 
 620   Jzp-110   -   -   -   -   1件:
6 
 621   K0706   -   -   -   -   1件:
6 
 622   Kdt-3594   -   -   -   -   1件:
6 
 623   Ketone ester drink   -   -   -   -   1件:
6 
 624   Kinoquinone (proposed)   -   -   -   -   1件:
6 
 625   Km-819   -   -   -   -   1件:
6 
 626   Kw-6002   -   -   -   -   1件:
6 
 627   Kw-6002 (istradefylline)   Istradefylline   D04641   1件: ADORA2A   7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   1件:
6 
 628   Kw-6356   -   -   -   -   1件:
6 
 629   Kw-6356 high dose   -   -   -   -   1件:
6 
 630   Kw-6356 low dose   -   -   -   -   1件:
6 
 631   Kw-6356 middle dose   -   -   -   -   1件:
6 
 632   Kw-6356 x dose   -   -   -   -   1件:
6 
 633   Kw-6356 y dose   -   -   -   -   1件:
6 
 634   Kw-6500   -   -   -   -   1件:
6 
 635   L-123 ioflupane   -   -   -   -   1件:
6 
 636   L-dopa   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 637   L-dopa/ modopar   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 638   L-dops   Droxidopa   D01277   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 639   L-methylfolate   Levomefolic acid   D09353   -   -   1件:
6 
 640   L-tyrosine   Tyrosine   D00022   -   -   2件:
6,
111 
 641   Lactobacillus plantarum   Lactobacillus plantarum   -   -   -   2件:
6,
156 
 642   Lactobacillus plantarum ps128   Lactobacillus plantarum   -   -   -   1件:
6 
 643   Lactose   Lactose   D00046, D03226   -   -   6件:
2,
6,
13,
97,
228,
310 
 644   Lcig   -   -   -   -   1件:
6 
 645   Lcig (duodopa)   -   -   -   -   1件:
6 
 646   Ld / be   -   -   -   -   1件:
6 
 647   Ld+ddci   -   -   -   -   1件:
6 
 648   Ld-ddci   -   -   -   -   1件:
6 
 649   Ld/cd   -   -   -   -   1件:
6 
 650   Leptin   Leptin   -   -   -   2件:
6,
265 
 651   Leucine   L-leucine   D00030   -   -   7件:
5,
6,
7,
127,
283,
284,
299 
 652   Levetiracetam   Levetiracetam   D00709   1件: SV2A   1件: ECM-receptor interaction   4件:
2,
4,
6,
13 
 653   Levodopa   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   7件:
2,
4,
6,
17,
90,
164,
201 
 654   Levodopa (delivered intravenously)   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 655   Levodopa (drug), intraduodenal administration   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 656   Levodopa (l-dopa)   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 657   Levodopa (l-dopa) + standard care   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 658   Levodopa / benserazid   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 659   Levodopa / benserazide 200 + 50 mg   Benserazide   D03082   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 660   Levodopa 100 mg / benserazide 25 mg   Benserazide   D03082   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 661   Levodopa 100 mg a cap   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 662   Levodopa 125 mg a cap   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 663   Levodopa 150 mg a cap   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 664   Levodopa 25mg/100mg   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 665   Levodopa 75 mg a cap   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 666   Levodopa acute challenge   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 667   Levodopa and carbidopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 668   Levodopa and carbidopa sc solution   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 669   Levodopa and carbidopa solution for sc administration   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 670   Levodopa and decarboxylase inhibitor   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 671   Levodopa and domperidone   Domperidone   D01745, D07868   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 672   Levodopa benserazide madopar   Benserazide   D03082   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 673   Levodopa benserazide teva italia   Benserazide   D03082   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 674   Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 675   Levodopa carbidopa intestinal gel (lcig)   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 676   Levodopa cr (controlled release)   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 677   Levodopa cyclops   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 678   Levodopa dc.it fu   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 679   Levodopa dispersible   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 680   Levodopa infusion   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 681   Levodopa mr   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 682   Levodopa powder for inhalation   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 683   Levodopa, carbidopa, entacapone   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 684   Levodopa, carbidopa, odm-104   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 685   Levodopa, decarboxylase inhibitor and comt inhibitor   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 686   Levodopa-carbidopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   2件:
6,
90 
 687   Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 688   Levodopa-carbidopa immediate release (lc-ir) tablets   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 689   Levodopa-carbidopa intestinal gel   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 690   Levodopa-carbidopa multilayer extended release tablet   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 691   Levodopa-carbidopa xl tablet (m)   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 692   Levodopa-carbidopa-entacapone   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 693   Levodopa/benserazide   Benserazide   D03082   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 694   Levodopa/benserazide 100/25 mg   Benserazide   D03082   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 695   Levodopa/benzeraside   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 696   Levodopa/benzerazide   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 697   Levodopa/carbidopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   2件:
6,
164 
 698   Levodopa/carbidopa (sinemet)   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 699   Levodopa/carbidopa 100/25   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 700   Levodopa/carbidopa hydrate   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 701   Levodopa/carbidopa solution   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 702   Levodopa/carbidopa(200mg/50mg)   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 703   Levodopa/carbidopa/entacapone   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 704   Levodopa/ddci   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 705   Liatermin   Liatermin   D04727   -   -   1件:
6 
 706   Liatermin (r-methugdnf)   Liatermin   D04727   -   -   1件:
6 
 707   Lidocaine   Lidocaine   D00358, D02086, D08127   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   8件:
6,
13,
46,
86,
168,
226,
231,
256 
 708   Lingzhi (ganoderma)   -   -   -   -   1件:
6 
 709   Liraglutide   Liraglutide   D06404   1件: GLP1R   3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   3件:
6,
75,
193 
 710   Lisparin   -   -   -   -   1件:
6 
 711   Lisuride   Lisuride   D01462, D08132   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   2件:
6,
86 
 712   Lisuride hydrogenmaleate   Lisuride   D01462, D08132   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 713   Lisuride transdermal system   Lisuride   D01462, D08132   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 714   Lisuride tts 10cm²   Lisuride   D01462, D08132   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 715   Lisuride tts 20cm²   Lisuride   D01462, D08132   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 716   Lixisenatide   Lixisenatide   D09729   1件: GLP1R   3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
6 
 717   Local anesthesia (lidocaine hydrochloride)   Lidocaine   D00358, D02086, D08127   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   1件:
6 
 718   Lodalès®   -   -   -   -   1件:
6 
 719   Lodosyn®   -   -   -   -   1件:
6 
 720   Lovastatin   Lovastatin   D00359   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   10件:
6,
34,
46,
79,
156,
160,
195,
206,
263,
310 
 721   Low dose affitope® pd03a + adjuvant   -   -   -   -   1件:
6 
 722   Lu 00-800   -   -   -   -   1件:
6 
 723   Lu ae04621   -   -   -   -   1件:
6 
 724   Lu af82422   -   -   -   -   1件:
6 
 725   Lubiprostone   Lubiprostone   D04790   1件: CLCN2   1件: Mineral absorption   4件:
6,
13,
290,
299 
 726   Ly03003   -   -   -   -   1件:
6 
 727   Ly300164   -   -   -   -   1件:
6 
 728   Ly3154207   -   -   -   -   1件:
6 
 729   Madopar   -   -   -   -   1件:
6 
 730   Madopar 125 mg, orodispersible tablet   -   -   -   -   1件:
6 
 731   Madopar 200+50 mg   -   -   -   -   1件:
6 
 732   Madopar lt   -   -   -   -   1件:
6 
 733   Madopar® 125   -   -   -   -   1件:
6 
 734   Madopar® 250   -   -   -   -   1件:
6 
 735   Madopar® hbs   -   -   -   -   1件:
6 
 736   Madopar® hbs 125   -   -   -   -   1件:
6 
 737   Magnesium   Magnesium   -   -   -   15件:
6,
11,
13,
46,
64,
93,
97,
166,
225,
235,
284,
291,
296,
297,
298 
 738   Magnesium oxide   Magnesium oxide   D01167   -   -   3件:
6,
166,
291 
 739   Maltodextrin   Maltodextrin   D02329   -   -   4件:
6,
13,
96,
97 
 740   Mannitol   Mannitol   D00062   -   -   3件:
6,
96,
299 
 741   Mantadix   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 742   Mars   -   -   -   -   1件:
6 
 743   Masitinib   Masitinib   D10229   1件: KIT   11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway   6件:
2,
5,
6,
13,
46,
96 
 744   Masitinib mesylate   Masitinib   D10229   1件: KIT   11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway   6件:
2,
5,
6,
13,
46,
96 
 745   Me2125   -   -   -   -   1件:
6 
 746   Medi1341   -   -   -   -   1件:
6 
 747   Melatonin   Melatonin   D08170   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   8件:
6,
13,
46,
49,
90,
97,
144,
202 
 748   Melatonin pr   Melatonin   D08170   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   1件:
6 
 749   Melatonin(circadin®)   Melatonin   D08170   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   1件:
6 
 750   Melevodopa   Melevodopa   D07304   -   -   1件:
6 
 751   Melevodopa and decarboxylase inhibitor   Melevodopa   D07304   -   -   1件:
6 
 752   Melperon   -   -   -   -   1件:
6 
 753   Melperone   Melperone   D07309   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 754   Melperone hcl   Melperone   D07309   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 755   Memantin   Memantine   D04905, D08174   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 756   Memantin orion   Memantine   D04905, D08174   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 757   Memantine   Memantine   D04905, D08174   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   7件:
2,
6,
8,
13,
49,
127,
205 
 758   Memantine hydrochloride   Memantine   D04905, D08174   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   3件:
2,
6,
127 
 759   Mesencephalic neuronal precursor cells   -   -   -   -   1件:
6 
 760   Mesenchymal stem cells   -   -   -   -   11件:
2,
6,
13,
20,
49,
51,
60,
96,
222,
274,
299 
 761   Mestinon   Pyridostigmine   D00487   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   3件:
3,
6,
11 
 762   Metformin   Metformin   D00944, D04966   2件: PRKAA1, PRKAA2   19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy (HCM), Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease (NAFLD), Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway   16件:
6,
13,
46,
49,
67,
75,
77,
81,
86,
113,
158,
206,
225,
233,
265,
285 
 763   Methylphenidate   Methylphenidate   D01296, D04999   2件: SLC6A2, SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   7件:
6,
13,
34,
84,
113,
179,
206 
 764   Methylphenidate (mpd)   Methylphenidate   D01296, D04999   2件: SLC6A2, SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   1件:
6 
 765   Methylphenidate hydrochloride   Methylphenidate   D01296, D04999   2件: SLC6A2, SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   2件:
6,
13 
 766   Mid dose anavex2-73   -   -   -   -   1件:
6 
 767   Midazolam   Midazolam   D00550, D00696, D05028   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   10件:
2,
3,
6,
13,
46,
70,
96,
97,
231,
298 
 768   Midodrine   Midodrine   D01307, D08220   3件: ADRA1A, ADRA1B, ADRA1D   7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   3件:
6,
17,
58 
 769   Minocycline   Minocycline   D00850, D05045   -   -   13件:
2,
6,
8,
13,
46,
85,
90,
94,
162,
201,
206,
280,
299 
 770   Minodronic acid   Minodronic acid   -   -   -   4件:
6,
46,
93,
95 
 771   Mirabegron   Mirabegron   D09535   1件: ADRB3   7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway   3件:
6,
13,
226 
 772   Mirapex   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 773   Mirapex (pramipexole)   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 774   Mirapex er   -   -   -   -   1件:
6 
 775   Mirapex la   -   -   -   -   1件:
6 
 776   Mirapexin   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 777   Mirapexin extended release various strengths   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 778   Mirapexin*30cpr 0,7mg   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 779   Mitoq   -   -   -   -   1件:
6 
 780   Mk0657   -   -   -   -   1件:
6 
 781   Moclobemide   Moclobemide   D02561   1件: MAOA   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 782   Modafinil   Modafinil   D01832   -   -   4件:
6,
13,
49,
93 
 783   Modafinil 50mg   Modafinil   D01832   -   -   1件:
6 
 784   Modiodal   -   -   -   -   1件:
6 
 785   Modopar   -   -   -   -   1件:
6 
 786   Monoamine oxidase b inhibitors   -   -   -   -   1件:
6 
 787   Motilium   -   -   -   -   2件:
6,
230 
 788   Moxifloxacin   Moxifloxacin   D00874, D08237   -   -   8件:
2,
6,
46,
49,
85,
86,
240,
299 
 789   Moxifloxacin infusion   Moxifloxacin   D00874, D08237   -   -   1件:
6 
 790   Moxifloxacina cloridrato   -   -   -   -   1件:
6 
 791   Muscimol   Muscimol   -   -   -   1件:
6 
 792   Mémantine   -   -   -   -   1件:
6 
 793   N-0923   -   -   -   -   1件:
6 
 794   N-acetylcysteine   Acetylcysteine   D00221   -   -   10件:
6,
13,
19,
20,
49,
58,
85,
111,
164,
299 
 795   N-acetylcysteine capsule   Acetylcysteine   D00221   -   -   1件:
6 
 796   N.a.   -   -   -   -   8件:
3,
6,
8,
13,
46,
97,
240,
256 
 797   N04bd02   -   -   -   -   1件:
6 
 798   Nabilone   Nabilone   D05099   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   2件:
6,
13 
 799   Nabilone 0.25 mg   Nabilone   D05099   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   1件:
6 
 800   Nacom   -   -   -   -   1件:
6 
 801   Nacom 100   -   -   -   -   1件:
6 
 802   Nacom levodopa+cardidopa   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 803   Nalmefene   Nalmefene   D05111   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 804   Naloxone   Naloxone   D01340, D08249   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   2件:
6,
226 
 805   Naltrexone   Naltrexone   D02095, D05113   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   11件:
6,
10,
13,
40,
41,
42,
43,
44,
45,
96,
97 
 806   Nardil   Phenelzine   D00505, D08349   2件: MAOA, MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 807   Nbtx-001   -   -   -   -   1件:
6 
 808   Nd0611   -   -   -   -   1件:
6 
 809   Nd0612   -   -   -   -   1件:
6 
 810   Nd0612 (levodopa/carbidopa solution)   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 811   Nd1421   -   -   -   -   1件:
6 
 812   Nd1587   -   -   -   -   1件:
6 
 813   Nd1589   -   -   -   -   1件:
6 
 814   Nd1590   -   -   -   -   1件:
6 
 815   Nd1702   -   -   -   -   1件:
6 
 816   Nebicapone   Nebicapone   -   -   -   1件:
6 
 817   Nelotanserin   Nelotanserin   D09645   1件: HTR2A   5件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse   1件:
6 
 818   Neridronic acid   Neridronic acid   -   -   -   1件:
6 
 819   Nerixia*im ev 1f 25mg   -   -   -   -   1件:
6 
 820   Neu-120   -   -   -   -   1件:
6 
 821   Neupro   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 822   Neupro 2 mg/24 h transdermal patch   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 823   Neupro 2mg/24 h transdermal patch   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 824   Neupro 2mg/24h transdermal patch   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 825   Neupro 4 mg/24 h transdermal patch   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 826   Neupro 4mg/24 h transdermal patch   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 827   Neupro 4mg/24h transdermal patch   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 828   Neupro 4mg/24hr transdermal patch   -   -   -   -   1件:
6 
 829   Neupro 6 mg/24 h transdermal patch   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 830   Neupro 6mg/24 h transdermal patch   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 831   Neupro 6mg/24h transdermal patch   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 832   Neupro 8 mg/24 h transdermal patch   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 833   Neupro 8mg/24h transdermal patch   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 834   Neupro*28cer 2mg/24h   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 835   Neupro*28cer 4mg/24h   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 836   Neupro*28cer 6mg/24h   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 837   Neupro*28cer 8mg/24h   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 838   Neupro*7cer 4mg/24h   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 839   Neupro*7cer 6mg/24h   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 840   Neupro*7cer 8mg/24h   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 841   Neupro®   -   -   -   -   1件:
6 
 842   Neuraceq   -   -   -   -   1件:
6 
 843   Neurobloc   -   -   -   -   1件:
6 
 844   Neuroepo   -   -   -   -   1件:
6 
 845   Neurohormonal mechanisms   -   -   -   -   2件:
6,
127 
 846   Neurpro   -   -   -   -   1件:
6 
 847   Niacin   Niacin   D00049   -   -   3件:
6,
78,
265 
 848   Niacinamide   Nicotinamide   D00036   -   -   4件:
5,
6,
13,
67 
 849   Nicorette 10mg/ 16 h   Nicotine   D03365, D05156, D05157   16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   5件: Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   1件:
6 
 850   Nicorette 15 mg/ 16 h   Nicotine   D03365, D05156, D05157   16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   5件: Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   1件:
6 
 851   Nicorette 5 mg/ 16 h   Nicotine   D03365, D05156, D05157   16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   5件: Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   1件:
6 
 852   Nicotinamide   Nicotinamide   D00036   -   -   3件:
6,
49,
162 
 853   Nicotinamide riboside   Nicotinamide riboside   -   -   -   1件:
6 
 854   Nicotine   Nicotine   D03365, D05156, D05157   16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   5件: Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   2件:
6,
84 
 855   Nicotine gum   Nicotine   D03365, D05156, D05157   16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   5件: Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   1件:
6 
 856   Nicotine nasal spray 10 mg/ml (0.5 mg/spray)   Nicotine   D03365, D05156, D05157   16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   5件: Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   1件:
6 
 857   Nicotine patch   Nicotine   D03365, D05156, D05157   16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   5件: Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   2件:
6,
84 
 858   Nicotine transdermal patch   Nicotine   D03365, D05156, D05157   16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   5件: Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   1件:
6 
 859   Nicotinell   -   -   -   -   1件:
6 
 860   Nicotinell 17,5 mg/24-stunden-pflaster   -   -   -   -   1件:
6 
 861   Nicotinell 35 mg/24-stunden-pflaster   -   -   -   -   1件:
6 
 862   Nilotinib   Nilotinib   D08953   4件: ABL1, KIT, PDGFRA, PDGFRB   33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Viral myocarditis   5件:
6,
8,
34,
51,
86 
 863   Nilotinib 150mg oral capsule [tasigna]   Nilotinib   D08953   4件: ABL1, KIT, PDGFRA, PDGFRB   33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Viral myocarditis   1件:
6 
 864   Nilotinib 300mg oral capsule [tasigna]   Nilotinib   D08953   4件: ABL1, KIT, PDGFRA, PDGFRB   33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Viral myocarditis   1件:
6 
 865   Nitrogen   Nitrogen   D00083   -   -   5件:
5,
6,
17,
211,
299 
 866   Nly01   -   -   -   -   1件:
6 
 867   Nmda   Ketamine   D00711, D08098   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 868   Normal saline   -   -   -   -   14件:
6,
17,
22,
36,
46,
49,
60,
94,
96,
211,
226,
276,
296,
299 
 869   Northera   Droxidopa   D01277   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 870   Nortriptyline   Nortriptyline   D00816, D08288   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   2件:
6,
226 
 871   Npc transplantation   -   -   -   -   1件:
6 
 872   Nr2b nmda antagonist cp-101,606 (traxoprodil)   Ketamine   D00711, D08098   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 873   Ns 2330   -   -   -   -   1件:
6 
 874   Ns2330   -   -   -   -   1件:
6 
 875   Nt 101   -   -   -   -   4件:
5,
6,
7,
17 
 876   Ntcell implantation   -   -   -   -   1件:
6 
 877   Null   -   -   -   -   17件:
6,
13,
14,
15,
28,
37,
46,
49,
51,
63,
86,
90,
96,
97,
107,
145,
271 
 878   Nw-1015   -   -   -   -   1件:
6 
 879   Nw-1015e, emd 1195686, msc2191632b   -   -   -   -   1件:
6 
 880   Nyx-458   -   -   -   -   1件:
6 
 881   Oc oral solution treatment a   -   -   -   -   1件:
6 
 882   Oc oral solution treatment b   -   -   -   -   1件:
6 
 883   Oc oral solution treatment c   -   -   -   -   1件:
6 
 884   Oc oral solution treatment d   -   -   -   -   1件:
6 
 885   Odm-101   -   -   -   -   1件:
6 
 886   Odm-101 105mg carbidopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 887   Odm-101 65mg carbidopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 888   Odm-104   -   -   -   -   1件:
6 
 889   Omeprazole   Omeprazole   D00455, D01207, D05259, D05261   2件: ATP4A, ATP4B   4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation   15件:
6,
8,
13,
46,
51,
85,
96,
97,
98,
225,
271,
282,
294,
298,
299 
 890   Onabotulinumtoxin a injection   -   -   -   -   1件:
6 
 891   Onabotulinumtoxina   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   3件:
6,
13,
226 
 892   Ongentys   Opicapone   D10825   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 893   Ono-2160/cd   -   -   -   -   1件:
6 
 894   Ono-2370   -   -   -   -   1件:
6 
 895   Ono-2506po   -   -   -   -   2件:
2,
6 
 896   Opicapone   Opicapone   D10825   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 897   Opicapone (opc)   Opicapone   D10825   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 898   Optimal drug therapy   -   -   -   -   1件:
6 
 899   Optimized antiparkinsonian treatment   -   -   -   -   1件:
6 
 900   Oral escitalopram   Escitalopram   D02567, D07704, D07913   1件: SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   1件:
6 
 901   Oral levodopa and carbidopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 902   Oral levodopa/carbidopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 903   Orally disintegrating selegiline (zelapar)   Selegiline   D00785, D03731   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 904   Osu 6162 similar to (-)-osu 6162   -   -   -   -   1件:
6 
 905   Osu6162 similar to (-)-osu 6162   -   -   -   -   2件:
6,
8 
 906   Other nervous system drugs   -   -   -   -   2件:
6,
13 
 907   Other parkinson's disease treatments   -   -   -   -   1件:
6 
 908   Over-encapsulated entacapone tablets   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 909   Over-encapsulated modafinil   Modafinil   D01832   -   -   1件:
6 
 910   Oxaloacetate (oaa)   -   -   -   -   1件:
6 
 911   Oxb-102   -   -   -   -   1件:
6 
 912   Oxybate   Gamma-hydroxybutyric acid   -   -   -   3件:
6,
120,
149 
 913   Oxybuprocaine   Oxybuprocaine   D01768, D08319   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   1件:
6 
 914   Oxybutynin   Oxybutynin   D00465, D00722   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   1件:
6 
 915   Oxybutynin and darifenacin   Darifenacin   D01699, D03654   1件: CHRM3   9件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction   1件:
6 
 916   Oxybutynin hydrochloride   Oxybutynin   D00465, D00722   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   1件:
6 
 917   Oxycodone   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   7件:
6,
13,
46,
70,
226,
231,
298 
 918   Oxycodone/naloxone prolonged release tablets   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 919   P2b001   -   -   -   -   1件:
6 
 920   P2b001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 921   P2b001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 922   Paracetamol   Acetaminophen   D00217   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   5件:
3,
6,
13,
35,
46 
 923   Parapres   -   -   -   -   1件:
6 
 924   Parcopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 925   Pardaprunox   -   -   -   -   1件:
6 
 926   Pardoprunox   Pardoprunox   D09397   3件: DRD2, DRD3, HTR1A   10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway   1件:
6 
 927   Pardoprunox hydrochloride   Pardoprunox   D09397   3件: DRD2, DRD3, HTR1A   10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway   1件:
6 
 928   Paroxetine   Paroxetine   D02260, D02362, D05374, D05375   1件: SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
6,
13,
46 
 929   Pbf-509   -   -   -   -   1件:
6 
 930   Pd patients h&y=1.5-2 medications off   -   -   -   -   1件:
6 
 931   Pd patients h&y=1.5-2 medications on   -   -   -   -   1件:
6 
 932   Pd patients h&y=3 medications off   -   -   -   -   1件:
6 
 933   Pd patients h&y=3 medications on   -   -   -   -   1件:
6 
 934   Pd vitamin supplementation   -   -   -   -   1件:
6 
 935   Perampanel   Perampanel   D08964   4件: GRIA1, GRIA2, GRIA3, GRIA4   13件: Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Transcriptional misregulation in cancer, cAMP signaling pathway   3件:
2,
6,
144 
 936   Pergolide   Pergolide   D00502, D08339   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 937   Pf-06412562   -   -   -   -   1件:
6 
 938   Pf-06649751   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 939   Pf-06649751 high dose (15 mg qd)   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 940   Pf-06649751 low dose (1 mg qd)   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 941   Pf-06649751 middle dose 1 (3 mg qd)   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 942   Pf-06649751 middle dose 2 (7 mg qd)   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 943   Pf-06669571   -   -   -   -   1件:
6 
 944   Pharmacological treatment   -   -   -   -   1件:
6 
 945   Phenylbutyrate   Phenylbutyric acid   D05868   -   -   10件:
2,
3,
6,
8,
93,
94,
244,
251,
297,
299 
 946   Piclozotan   Piclozotan   -   -   -   1件:
6 
 947   Pilocarpine   Pilocarpine   D00525, D02200, D05478   2件: CHRM2, CHRM3   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   3件:
6,
53,
299 
 948   Pimavanserin   Pimavanserin   -   -   -   1件:
6 
 949   Pimavanserin (acp-103)   Pimavanserin   -   -   -   1件:
6 
 950   Pimavanserin tartrate   Pimavanserin   -   -   -   1件:
6 
 951   Pimavanserin tartrate (acp-103)   Pimavanserin   -   -   -   1件:
6 
 952   Pioglitazone   Pioglitazone   D00945, D08378   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   17件:
2,
6,
13,
15,
20,
46,
49,
65,
67,
78,
81,
86,
96,
229,
265,
298,
299 
 953   Piribedil   Piribedil   D07305   2件: DRD2, DRD3   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 954   Piribedil (clarium)   Piribedil   D07305   2件: DRD2, DRD3   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 955   Pitolisant   Pitolisant   D10749   1件: HRH3   1件: Neuroactive ligand-receptor interaction   1件:
6 
 956   Pittsburgh compound b   Pittsburgh compound b   -   -   -   2件:
6,
127 
 957   Pk-merz® 200mg/500ml inj(amantadine) , normal saline 500ml inj   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 958   Placebo   -   -   -   -   20件:
3,
6,
13,
14,
40,
46,
49,
50,
51,
66,
67,
79,
85,
86,
88,
96,
97,
144,
149,
226 
 959   Plantago ovata husk   -   -   -   -   1件:
6 
 960   Positron emission tomography using [11 carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11c]-dasb) and [18 fluorine]-altanserin ([18f]-altanserin)   Activated charcoal   D03251   -   -   1件:
6 
 961   Positron emission tomography using [18 fluorine]-altanserin ([18f]-altanserin)   -   -   -   -   1件:
6 
 962   Pr oxycodone   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 963   Pr001a   -   -   -   -   1件:
6 
 964   Pramipexol   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 965   Pramipexol extended release   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 966   Pramipexol immediate release   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 967   Pramipexole   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   2件:
2,
6 
 968   Pramipexole 0.125 mg tablets   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 969   Pramipexole 0.5 mg tablets   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 970   Pramipexole dihydrochloride   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 971   Pramipexole dihydrochloride extended-release tablets   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 972   Pramipexole dihydrochloride monohydrate   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 973   Pramipexole dihydrochloride monohydrate extended release   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 974   Pramipexole er   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 975   Pramipexole extended release   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 976   Pramipexole extended release tablet   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 977   Pramipexole immediate release   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 978   Pramipexole immediate release tablet   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 979   Pramipexole ir   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 980   Pramipexole or ropinirole   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 981   Pramipexole sr   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 982   Preladenant   Preladenant   D09717   1件: ADORA2A   7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   1件:
6 
 983   Preladenant 10 mg tablet   Preladenant   D09717   1件: ADORA2A   7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   1件:
6 
 984   Preladenant 2 mg tablet   Preladenant   D09717   1件: ADORA2A   7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   1件:
6 
 985   Preladenant 5 mg tablet   Preladenant   D09717   1件: ADORA2A   7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   1件:
6 
 986   Premarin ®   -   -   -   -   1件:
6 
 987   Pridopidine   Pridopidine   D09953   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   2件:
6,
8 
 988   Prim-dj2727   -   -   -   -   1件:
6 
 989   Primary cervical dystonia (trihexyphenidyl)   Trihexyphenidyl   D00787, D08638   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   1件:
6 
 990   Probiotic   -   -   -   -   5件:
2,
6,
96,
193,
266 
 991   Probiotic capsule   -   -   -   -   1件:
6 
 992   Prolonged release tablet   -   -   -   -   1件:
6 
 993   Prolopa®   -   -   -   -   1件:
6 
 994   Propofol   Propofol   D00549   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   8件:
6,
21,
22,
34,
46,
84,
98,
296 
 995   Propofol-lipuro   Propofol   D00549   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   1件:
6 
 996   Propranolol   Propranolol   D00483, D08443   3件: ADRB1, ADRB2, ADRB3   11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway   5件:
6,
158,
167,
227,
278 
 997   Propranolol hcl cf 40 mg tablet   Propranolol   D00483, D08443   3件: ADRB1, ADRB2, ADRB3   11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 998   Prosavin   -   -   -   -   1件:
6 
 999   Proscar*30cpr riv 5mg   Finasteride   D00321   1件: SRD5A2   2件: Prostate cancer, Steroid hormone biosynthesis   1件:
6 
 1000   Prx002   -   -   -   -   1件:
6 
 1001   Pxt002331   -   -   -   -   1件:
6 
 1002   Pxt002331 - 20mg   -   -   -   -   1件:
6 
 1003   Pxt002331 - dose 1   -   -   -   -   1件:
6 
 1004   Pxt002331 - dose 2   -   -   -   -   1件:
6 
 1005   Pym50028   -   -   -   -   1件:
6 
 1006   Pyridostigmine   Pyridostigmine   D00487   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   4件:
3,
6,
11,
256 
 1007   Pyridostigmine bromide   Pyridostigmine   D00487   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   3件:
3,
6,
256 
 1008   Quetiapine   Quetiapine   D00458, D08456   2件: DRD2, HTR2A   11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway   2件:
6,
13 
 1009   R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride   Benzofuran   -   -   -   1件:
6 
 1010   R-methugdnf   Liatermin   D04727   -   -   1件:
6 
 1011   Raav-gad   -   -   -   -   1件:
6 
 1012   Raclopride   Raclopride   -   -   -   4件:
5,
6,
7,
17 
 1013   Ramelteon   Ramelteon   D02689   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   3件:
6,
8,
46 
 1014   Rasagilin   -   -   -   -   2件:
5,
6 
 1015   Rasagilina   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1016   Rasagilina mesilato (12 weeks)   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1017   Rasagiline   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   4件:
2,
5,
6,
17 
 1018   Rasagiline 1 mg capsule   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1019   Rasagiline 1mg tablet   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1020   Rasagiline 2 mg tablet   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1021   Rasagiline mesilate   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   3件:
2,
5,
6 
 1022   Rasagiline mesylate   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   2件:
6,
17 
 1023   Rasagiline mesylate 1.0 mg   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1024   Rasagiline mesylate plus mirapex   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1025   Rasagiline mesylate with levodopa   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1026   Rasagiline mesylate with requip   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1027   Rasagiline tablets   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1028   Recombinant human cerebral dopamine neurotrophic factor   Dopamine   D00633, D07870   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1029   Recombinant-methionyl human glial cell line-derived neurotrophic factor   -   -   -   -   1件:
6 
 1030   Reduced glutathione   Glutathione   D00014, D00031   -   -   2件:
6,
299 
 1031   Reduced glutathione 100mg   Glutathione   D00014, D00031   -   -   1件:
6 
 1032   Reduced glutathione 200mg   Glutathione   D00014, D00031   -   -   1件:
6 
 1033   Remifentanil   Remifentanil   D01177, D08473   1件: OPRM1   3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction   2件:
6,
70 
 1034   Remifentanyl   Remifentanil   D01177, D08473   1件: OPRM1   3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction   1件:
6 
 1035   Reminyl retard   -   -   -   -   1件:
6 
 1036   Repaglinide   Repaglinide   D00594   2件: ABCC8, KCNJ11   4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus   2件:
6,
299 
 1037   Requip   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   2件:
6,
309 
 1038   Requip pr   -   -   -   -   1件:
6 
 1039   Requip prolonged release   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1040   Requip xl prolonged-release   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1041   Requip*21cpr 5mg   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1042   Requip*28cpr 8mg r.p.   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1043   Requip-lp   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1044   Requip-modutab   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1045   Requip-modutab , 2mg   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1046   Requip-modutab , 4mg   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1047   Requip-modutab , 8mg   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1048   Requip-modutab, 2mg   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1049   Requip-modutab, 4mg   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1050   Requip-modutab, 8mg   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1051   Resistant maltodextrin   Maltodextrin   D02329   -   -   1件:
6 
 1052   Resistant starch   -   -   -   -   1件:
6 
 1053   Rifampicin   Rifampicin   D00211   -   -   4件:
6,
17,
46,
299 
 1054   Rifampin   Rifampicin   D00211   -   -   5件:
6,
13,
84,
86,
299 
 1055   Rifampin 300mg bid + istradefylline 40mg day 8 only   Istradefylline   D04641   1件: ADORA2A   7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   1件:
6 
 1056   Rifaximin   Rifaximin   D02554   -   -   5件:
6,
96,
97,
99,
296 
 1057   Rifaximin 550 mg   Rifaximin   D02554   -   -   1件:
6 
 1058   Ritalin   Methylphenidate   D01296, D04999   2件: SLC6A2, SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   2件:
6,
13 
 1059   Rivastigmine   Rivastigmine   D02558, D03822   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   3件:
5,
6,
13 
 1060   Rivastigmine capsule   Rivastigmine   D02558, D03822   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
6 
 1061   Rivastigmine patch 9.5 cm2   Rivastigmine   D02558, D03822   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
6 
 1062   Rivastigmine transdermal patch   Rivastigmine   D02558, D03822   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   2件:
6,
13 
 1063   Rm-131   -   -   -   -   1件:
6 
 1064   Ro7046015   -   -   -   -   1件:
6 
 1065   Rop+l-dopa   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1066   Ropinirole   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   3件:
6,
74,
309 
 1067   Ropinirole (as hydrochloride)   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1068   Ropinirole controlled-release (requip cr) for rls   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1069   Ropinirole cr 2mg tablet   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1070   Ropinirole cr 8mg tablet   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1071   Ropinirole hydrochloride   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   2件:
6,
309 
 1072   Ropinirole hydrochloride extended-release tablet   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1073   Ropinirole hydrochloride extended-release tablet placebo   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1074   Ropinirole hydrochloride prolonged release   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1075   Ropinirole immediate release   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1076   Ropinirole implant   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1077   Ropinirole ir   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1078   Ropinirole ir tablets   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1079   Ropinirole monotherapy   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1080   Ropinirole oral product   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1081   Ropinirole pr   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1082   Ropinirole pr, 2mg   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1083   Ropinirole pr/xr   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1084   Ropinirole pr/xr tablets   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1085   Ropinirole prolonged release   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1086   Ropinirole prolonged release/extended release(pr/xr)   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1087   Ropinirole xl   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1088   Ropinirole xl (formerly cr)   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1089   Ropinirole/l-dopa   Ropinirole   D00784, D08489   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1090   Rosuvastatin   Rosuvastatin   D01915, D08492   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   8件:
6,
46,
49,
51,
79,
96,
271,
299 
 1091   Rotigotin   -   -   -   -   1件:
6 
 1092   Rotigotina   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1093   Rotigotine   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1094   Rotigotine (reference product pr 2.1.1)   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1095   Rotigotine (test product pr 2.3.1)   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1096   Rotigotine hydrochloride   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1097   Rotigotine nasal spray   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1098   Rotigotine transdermal patch   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1099   Rotigotine transdermal patch 2mg/24h(10cm2)   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1100   Rotigotine transdermal patch 4mg/24h (20cm2)   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1101   Rotigotine transdermal patch 6mg/24h (30cm2)   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1102   Rotigotine transdermal patch 8mg/24h (40cm2)   Rotigotine   D05768   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1103   Rozerem   Ramelteon   D02689   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   1件:
6 
 1104   Rq-00000010   -   -   -   -   1件:
6 
 1105   Rvg 55618   -   -   -   -   1件:
6 
 1106   Rvt-101 35 mg   -   -   -   -   1件:
6 
 1107   Rytary 145 mg   -   -   -   -   1件:
6 
 1108   Rytary 195 mg   -   -   -   -   1件:
6 
 1109   S 90049   -   -   -   -   1件:
6 
 1110   S 90049 - f36   -   -   -   -   1件:
6 
 1111   S 90049 - f38   -   -   -   -   1件:
6 
 1112   S.c. apomorphine   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1113   Safety observation   -   -   -   -   1件:
6 
 1114   Safinamida   Safinamide   D10158   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1115   Safinamide   Safinamide   D10158   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   2件:
6,
17 
 1116   Safinamide + levodopa   Safinamide   D10158   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1117   Safinamide metansolfonato (12 weeks)   Safinamide   D10158   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1118   Safinamide methanesulfonate   Safinamide   D10158   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   2件:
6,
17 
 1119   Safinamide methanesulfonate 100mg   Safinamide   D10158   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1120   Safinamide methanesulfonate 150mg   Safinamide   D10158   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1121   Safinamide methansulfonate   Safinamide   D10158   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1122   Safinamide, mao-b inhibitor   Safinamide   D10158   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1123   Sage   Sage   -   -   -   2件:
6,
8 
 1124   Sage leaf   Sage   -   -   -   1件:
6 
 1125   Sage-217   Sage   -   -   -   1件:
6 
 1126   Saline   Sodium chloride   D02056   -   -   10件:
6,
13,
17,
53,
67,
78,
86,
97,
168,
299 
 1127   Saline intranasal delivery   -   -   -   -   1件:
6 
 1128   Sam-e   Ademetionine   D07128   -   -   1件:
6 
 1129   Same   Ademetionine   D07128   -   -   15件:
6,
14,
22,
43,
44,
46,
47,
49,
50,
60,
84,
93,
96,
97,
172 
 1130   Saracatinib   Saracatinib   D09664   2件: ABL1, SRC   45件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection   2件:
6,
89 
 1131   Sarcosine   Sarcosine   -   -   -   1件:
6 
 1132   Sarcosine capsule   Sarcosine   -   -   -   1件:
6 
 1133   Sargramostim   Sargramostim   D05803   1件: CSF2RA   4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer   6件:
6,
28,
60,
62,
96,
229 
 1134   Sarizotan   Sarizotan   -   -   -   2件:
6,
156 
 1135   Sarizotan hc1   Sarizotan   -   -   -   1件:
6 
 1136   Sarizotan hcl   Sarizotan   -   -   -   1件:
6 
 1137   Sarizotan hydrochloride   Sarizotan   -   -   -   2件:
6,
156 
 1138   Sch 420814   -   -   -   -   1件:
6 
 1139   Sch 420814 10 mg   -   -   -   -   1件:
6 
 1140   Sch 420814 100 mg   -   -   -   -   1件:
6 
 1141   Sch 900800   -   -   -   -   1件:
6 
 1142   Selegiline   Selegiline   D00785, D03731   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1143   Selegiline hcl 5 pch   Selegiline   D00785, D03731   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1144   Semaglutide   Semaglutide   D10025   1件: GLP1R   3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
6 
 1145   Semi continuous intra-oral administration of ld/cd   -   -   -   -   1件:
6 
 1146   Sep-363856   -   -   -   -   1件:
6 
 1147   Ser-214   -   -   -   -   1件:
6 
 1148   Serine   Serine   D00016   -   -   3件:
2,
6,
86 
 1149   Seroquel   Quetiapine   D00458, D08456   2件: DRD2, HTR2A   11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway   1件:
6 
 1150   Sertraline   Sertraline   D00825, D02360   1件: SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   2件:
6,
206 
 1151   Sevoflurane   Sevoflurane   D00547   -   -   5件:
6,
21,
22,
98,
296 
 1152   Sifol   -   -   -   -   1件:
6 
 1153   Sifrol   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1154   Sifrol 0,088   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1155   Sifrol 0,18   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1156   Sifrol 0,35   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1157   Sifrol 0,7   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1158   Sifrol, 0,35 mg tablette   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1159   Sifrol, 0,70 mg tablette   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1160   Sifrol®   -   -   -   -   1件:
6 
 1161   Sildenafil   Sildenafil   D02229, D08514   1件: PDE5A   3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway   15件:
6,
46,
50,
51,
85,
86,
113,
210,
211,
212,
225,
226,
278,
294,
299 
 1162   Silodosin   Silodosin   D01965   1件: ADRA1A   7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
6 
 1163   Simvastatin   Simvastatin   D00434   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   19件:
6,
13,
15,
34,
46,
49,
51,
66,
79,
86,
89,
94,
158,
162,
195,
265,
298,
299,
310 
 1164   Simvastatine   Simvastatin   D00434   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   2件:
6,
13 
 1165   Sinemet   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1166   Sinemet (comparator)   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1167   Sinemet (levodopa/carbidopa)   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1168   Sinemet 100 mg + 25 mg compresse   -   -   -   -   1件:
6 
 1169   Sinemet 125 mg   -   -   -   -   1件:
6 
 1170   Sinemet 200mg/50mg   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1171   Sinemet 25-100   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1172   Sinemet 25/100   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1173   Sinemet cr   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1174   Sinemet cr 25mg-100mg extended-release tablet   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1175   Sinemet ir   -   -   -   -   1件:
6 
 1176   Sinemet plus   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1177   Sinemet plus (levodopa/carbidopa)   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1178   Sinemet*50cpr 100mg+25mg   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1179   Sinemet®   -   -   -   -   1件:
6 
 1180   Sinemet® 100/25   -   -   -   -   1件:
6 
 1181   Sinemet® 100/25 mg   -   -   -   -   1件:
6 
 1182   Sinemet® controlled release (carbidopa/levodopa)   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1183   Sinemet® cr   -   -   -   -   1件:
6 
 1184   Sinemet® cr 100/25   -   -   -   -   1件:
6 
 1185   Sinemet® plus 25 mg/100 mg tablets   -   -   -   -   1件:
6 
 1186   Sinemet®-plus tablets   -   -   -   -   1件:
6 
 1187   Sirio*30cpr eff 25mg+100mg   -   -   -   -   1件:
6 
 1188   Sk&f101468   -   -   -   -   1件:
6 
 1189   Slv308   -   -   -   -   1件:
6 
 1190   Slv308 (mono) hydrochlori   -   -   -   -   1件:
6 
 1191   Slv308 (mono) hydrochloride   -   -   -   -   1件:
6 
 1192   Slv308 hydrochloride   -   -   -   -   1件:
6 
 1193   Smilagenin   Smilagenin   -   -   -   1件:
6 
 1194   Snd 919   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1195   Snd 919 cl2 y   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1196   Snd 919 cl2y   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1197   Snn0031   -   -   -   -   1件:
6 
 1198   Sodium chloride   Sodium chloride   D02056   -   -   13件:
6,
11,
13,
14,
34,
46,
51,
168,
193,
227,
228,
288,
299 
 1199   Sodium oxybate   Sodium oxybate   D05866   -   -   3件:
6,
120,
149 
 1200   Solifenacin   Solifenacin   D01269, D08522   1件: CHRM3   9件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction   1件:
6 
 1201   Solifenacin succinate (vesicare)   Solifenacin   D01269, D08522   1件: CHRM3   9件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction   1件:
6 
 1202   Solu-cortef   Hydrocortisone succinate   D01442   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   3件:
6,
81,
83 
 1203   Solu-cortef, powder for solution for injection, 100mg, and 'act-o-vial'   Hydrocortisone succinate   D01442   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
6 
 1204   Soy protein   -   -   -   -   2件:
6,
96 
 1205   Spheramine (bay86-5280)   -   -   -   -   1件:
6 
 1206   Spm 962   -   -   -   -   1件:
6 
 1207   Spm962   -   -   -   -   1件:
6 
 1208   Sqjz herbal mixtures   -   -   -   -   1件:
6 
 1209   Sr57667b   -   -   -   -   1件:
6 
 1210   Stalevo   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1211   Stalevo (levodopa/ carbidopa/ entacapone)   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 1212   Stalevo (levodopa/carbidopa/entacapona)   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1213   Stalevo 100   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1214   Stalevo 100 mg/ 25 mg/ 200 mg filmtabletten   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1215   Stalevo 100/25/200 mg   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1216   Stalevo 150   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1217   Stalevo 150/37.5/200 mg   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1218   Stalevo*100cpr 100/25/200mg   -   -   -   -   1件:
6 
 1219   Stalevo*100cpr 50/12,5/200mg   -   -   -   -   1件:
6 
 1220   Stalevo®   -   -   -   -   1件:
6 
 1221   Standard ld/cd   -   -   -   -   1件:
6 
 1222   Standard of care   -   -   -   -   8件:
6,
13,
14,
49,
51,
64,
79,
85 
 1223   Stilnoct   -   -   -   -   1件:
6 
 1224   Strattera   Atomoxetine   D02574, D07473   1件: SLC6A2   1件: Synaptic vesicle cycle   1件:
6 
 1225   Study drug   -   -   -   -   2件:
6,
13 
 1226   Subcutaneous apomorphine   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1227   Subcutaneous hydrocortisone 10mg   Hydrocortisone   D00088   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
6 
 1228   Subjects will undergo the 123-i ibvm imaging visit   -   -   -   -   1件:
6 
 1229   Sugar pill   -   -   -   -   7件:
6,
49,
67,
70,
86,
206,
226 
 1230   Sulfate   Sulfate ion   -   -   -   22件:
2,
6,
11,
13,
26,
34,
36,
46,
49,
60,
61,
64,
66,
79,
86,
96,
222,
226,
265,
296,
297,
299 
 1231   Sumanirole   Sumanirole   -   -   -   1件:
6 
 1232   Supplementation   -   -   -   -   1件:
6 
 1233   Supressi. t-diet plus range   -   -   -   -   1件:
6 
 1234   Suvorexant   Suvorexant   D10082   2件: HCRTR1, HCRTR2   1件: Neuroactive ligand-receptor interaction   3件:
5,
6,
13 
 1235   Syn120   -   -   -   -   1件:
6 
 1236   Tadalafil   Tadalafil   D02008   1件: PDE5A   3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway   6件:
6,
51,
75,
84,
86,
113 
 1237   Talampanel   Talampanel   D02696   4件: GRIA1, GRIA2, GRIA3, GRIA4   13件: Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Transcriptional misregulation in cancer, cAMP signaling pathway   2件:
2,
6 
 1238   Tasmar   Tolcapone   D00786   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   2件:
6,
28 
 1239   Tch346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt)   Hydrogen   -   -   -   1件:
6 
 1240   Td-9855   -   -   -   -   2件:
6,
17 
 1241   Technetium (99mtc) exametazime   Exametazime   D01109   -   -   1件:
6 
 1242   Terazosin   Terazosin   D00610, D08569   3件: ADRA1A, ADRA1B, ADRA1D   7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
6 
 1243   Terazosin 5 mg   Terazosin   D00610, D08569   3件: ADRA1A, ADRA1B, ADRA1D   7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
6 
 1244   Tesofensine   Tesofensine   -   -   -   2件:
6,
193 
 1245   Thn02   -   -   -   -   1件:
6 
 1246   Thn102 dosage a   -   -   -   -   1件:
6 
 1247   Thn102 dosage b   -   -   -   -   1件:
6 
 1248   Thn102 dosage c   -   -   -   -   1件:
6 
 1249   Tigan®   -   -   -   -   1件:
6 
 1250   Tolcapon   Tolcapone   D00786   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 1251   Tolcapone   Tolcapone   D00786   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   3件:
6,
28,
127 
 1252   Topiramate   Topiramate   D00537   36件: CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   48件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   5件:
6,
140,
144,
156,
193 
 1253   Topiramate (drug)   Topiramate   D00537   36件: CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   48件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 1254   Tozadenant   Tozadenant   D10174   1件: ADORA2A   7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   1件:
6 
 1255   Tozadenant (syn115) 120 mg bid   Tozadenant   D10174   1件: ADORA2A   7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   1件:
6 
 1256   Tozadenant (syn115) 180 mg bid   Tozadenant   D10174   1件: ADORA2A   7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   1件:
6 
 1257   Tozadenant (syn115) 240 mg bid   Tozadenant   D10174   1件: ADORA2A   7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   1件:
6 
 1258   Tozadenant (syn115) 60 mg bid   Tozadenant   D10174   1件: ADORA2A   7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   1件:
6 
 1259   Traditional chinese medicinal mixture (composed of roucongrong and adjuvant)   -   -   -   -   1件:
6 
 1260   Transdermal nicotine   Nicotine   D03365, D05156, D05157   16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   5件: Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   1件:
6 
 1261   Trigel   -   -   -   -   1件:
6 
 1262   Trihexyphenidyl   Trihexyphenidyl   D00787, D08638   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   2件:
5,
6 
 1263   Trimethobenzamide   Trimethobenzamide   D02733, D08643   -   -   1件:
6 
 1264   Trimethobenzamide hydrochloride   Trimethobenzamide   D02733, D08643   -   -   1件:
6 
 1265   Trivastal   Piribedil   D07305   2件: DRD2, DRD3   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1266   Tropicamide   Tropicamide   D00397   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   2件:
6,
19 
 1267   Tryptophan   L-tryptophan   D00020   -   -   1件:
6 
 1268   Tryptophan (trp) depletion   L-tryptophan   D00020   -   -   1件:
6 
 1269   Tvp-1012   -   -   -   -   1件:
6 
 1270   Tvp-1012 (1 mg/day) with levodopa   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1271   Tvp-1012 0.5mg   -   -   -   -   1件:
6 
 1272   Tvp-1012 1mg   -   -   -   -   1件:
6 
 1273   Tvp-1012 1mg with levodopa   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 1274   Tyrosine   Tyrosine   D00022   -   -   3件:
6,
86,
111 
 1275   Ub-312   -   -   -   -   1件:
6 
 1276   Ubiquinol   Ubiquinol   -   -   -   3件:
6,
8,
17 
 1277   Urate   Uric acid   -   -   -   1件:
6 
 1278   Ursodeoxycholic acid   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   8件:
6,
67,
84,
93,
94,
95,
96,
97 
 1279   V1512   -   -   -   -   1件:
6 
 1280   V1512 and entacapone   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 1281   V81444   -   -   -   -   1件:
6 
 1282   Valerian   Valerian   -   -   -   1件:
6 
 1283   Varenicline   Varenicline   D08669   2件: CHRNA4, CHRNB2   3件: Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   2件:
6,
18 
 1284   Varenicline tartrate   Varenicline   D08669   2件: CHRNA4, CHRNB2   3件: Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   1件:
6 
 1285   Variation of behaviors of parkinson's disease   -   -   -   -   1件:
6 
 1286   Vehicle   -   -   -   -   4件:
6,
36,
160,
192 
 1287   Venlafaxine   Venlafaxine   D00821, D08670   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
6,
13,
46 
 1288   Vineuro   -   -   -   -   1件:
6 
 1289   Vitamin b12   Cyanocobalamin   D00166, D03615, D03616, D03617   -   -   4件:
6,
201,
229,
299 
 1290   Vitamin b12 supplementation   Cyanocobalamin   D00166, D03615, D03616, D03617   -   -   1件:
6 
 1291   Vitamin b6   Pyridoxine   D02179, D08454   -   -   1件:
6 
 1292   Vitamin d3   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   11件:
6,
13,
20,
46,
49,
53,
60,
65,
96,
97,
299 
 1293   Vitamin d3 - high dose   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   1件:
6 
 1294   Vitamin e   Vitamin e   D02331   -   -   11件:
2,
6,
13,
20,
46,
90,
96,
97,
206,
299,
317 
 1295   Viusid/alzer   -   -   -   -   1件:
6 
 1296   Vr040   -   -   -   -   1件:
6 
 1297   Vr040/aspirair® inhaler   -   -   -   -   1件:
6 
 1298   Vy-aadc01   -   -   -   -   1件:
6 
 1299   Vy-aadc02   -   -   -   -   1件:
6 
 1300   Warfarin   Warfarin   D00564, D01280, D08682   2件: NQO1, VKORC1   5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis   10件:
6,
8,
13,
19,
46,
49,
66,
85,
88,
96 
 1301   Water   Water   D00001   -   -   18件:
2,
5,
6,
13,
17,
19,
35,
46,
53,
57,
63,
65,
67,
84,
97,
226,
278,
299 
 1302   Whey protein   -   -   -   -   2件:
6,
96 
 1303   White chocolate (0% cocoa)   Cocoa   -   -   -   1件:
6 
 1304   Wuling powder   -   -   -   -   1件:
6 
 1305   Xadago   Safinamide   D10158   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1306   Xadago (safinamide)   Safinamide   D10158   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1307   Xc130-a10h   -   -   -   -   1件:
6 
 1308   Xeomin   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   7件:
5,
6,
7,
13,
15,
17,
113 
 1309   Xiaoyao pill   -   -   -   -   1件:
6 
 1310   Xp21279   -   -   -   -   1件:
6 
 1311   Xp21279 and carbidopa (experimental)   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1312   Zelapar   Selegiline   D00785, D03731   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 1313   Zoledronic acid   Zoledronic acid   D01968, D06378, D06379, D08689   1件: FDPS   4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   9件:
6,
13,
46,
93,
95,
96,
274,
299,
333 
 1314   Zoledronic acid 5mg/bag 100ml inj   Zoledronic acid   D01968, D06378, D06379, D08689   1件: FDPS   4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
6 
 1315   Zolmitriptan   Zolmitriptan   D00415   2件: HTR1B, HTR1D   4件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway   1件:
6 
 1316   Zolpidem   Zolpidem   D00706, D08690   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   2件:
5,
6 
 1317   Zolpidem first dose   Zolpidem   D00706, D08690   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   1件:
6 
 1318   Zolpidem second dose   Zolpidem   D00706, D08690   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   1件:
6 
 1319   Zolpidem tartrate   Zolpidem   D00706, D08690   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   1件:
6 
 1320   Zonegran   Zonisamide   D00538   8件: CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   11件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus   1件:
6 
 1321   Zonisamide   Zonisamide   D00538   8件: CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   11件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus   1件:
6 
 1322   Zopiclone   Zopiclone   D01372   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   1件:
6 

先頭へ